1
|
Nowak A, Słowik Ł, Szcześniak M, Okła M, Osmola K, Wyganowska M. Osteonecrosis of the jaw: surgical treatment results before and during the COVID-19 pandemic in one of the reference hospitals in Poland. Eur Rev Med Pharmacol Sci 2024; 28:772-777. [PMID: 38305619 DOI: 10.26355/eurrev_202401_35077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/03/2024]
Abstract
OBJECTIVE The COVID-19 pandemic has had a huge impact not only on everyday life but, above all, on the functioning of medical entities. During its duration, there were problems with access to health care, including maxillofacial surgery departments. The aim of the study is to analyze how the pandemic affected the surgical results of the treatment of osteonecrosis of the jaws at the Clinic of Maxillofacial Surgery in Poznań which delivers services in maxillofacial surgery for almost 4.5 million inhabitants in Poland. PATIENTS AND METHODS We conducted a retrospective analysis of patients' medical records before and during the pandemic restrictions. The data was obtained by entering the appropriate passwords and ICD-10 diagnoses (e.g., M87) in the hospital's IT system. The obtained information was subjected to statistical analysis. RESULTS The number of patients before and during the pandemic did not differ significantly. During the COVID-19 pandemic, the waiting time of patients after admission to the hospital for surgery and the total time of hospitalization were shortened. The number of complications was similar in both groups. However, the waiting time for a follow-up visit was longer during restriction time. CONCLUSIONS The COVID-19 pandemic had an impact on the course of surgical treatment in patients with osteonecrosis of the jaws. The outcomes of the medical procedure remained consistent with the ones observed before the implementation of restrictions. This is likely due to the urgency of the illness. Despite the pandemic, a critical condition called osteonecrosis of the jaw was treated promptly.
Collapse
Affiliation(s)
- A Nowak
- Department of Maxillofacial Surgery, Poznan University of Medical Sciences, Poznan, Poland.
| | | | | | | | | | | |
Collapse
|
2
|
Sobolewska-Nowak J, Wachowska K, Nowak A, Orzechowska A, Szulc A, Płaza O, Gałecki P. Exploring the Heart-Mind Connection: Unraveling the Shared Pathways between Depression and Cardiovascular Diseases. Biomedicines 2023; 11:1903. [PMID: 37509542 PMCID: PMC10377477 DOI: 10.3390/biomedicines11071903] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2023] [Revised: 06/11/2023] [Accepted: 06/15/2023] [Indexed: 07/30/2023] Open
Abstract
Civilization diseases are defined as non-communicable diseases that affect a large part of the population. Examples of such diseases are depression and cardiovascular disease. Importantly, the World Health Organization warns against an increase in both of these. This narrative review aims to summarize the available information on measurable risk factors for CVD and depression based on the existing literature. The paper reviews the epidemiology and main risk factors for the coexistence of depression and cardiovascular disease. The authors emphasize that there is evidence of a link between depression and cardiovascular disease. Here, we highlight common risk factors for depression and cardiovascular disease, including obesity, diabetes, and physical inactivity, as well as the importance of the prevention and treatment of CVD in preventing depression and other mental disorders. Conversely, effective treatment of CVD can also help prevent depression and improve mental health outcomes. It seems advisable to introduce screening tests for depression in patients treated for cardiac reasons. Importantly, in patients treated for mood disorders, it is worth controlling CVD risk factors, for example, by checking blood pressure and pulse during routine visits. It is also worth paying attention to the mental condition of patients with CVD. This study underlines the importance of interdisciplinary co-operation.
Collapse
Affiliation(s)
| | - Katarzyna Wachowska
- Department of Adult Psychiatry, Medical Univeristy of Lodz, 90-419 Lodz, Poland
| | - Artur Nowak
- Department of Immunopathology, Medical Univeristy of Lodz, 90-419 Lodz, Poland
| | - Agata Orzechowska
- Department of Adult Psychiatry, Medical Univeristy of Lodz, 90-419 Lodz, Poland
| | - Agata Szulc
- Psychiatric Clinic of the Faculty of Health Sciences, Medical University of Warsaw, 02-091 Warsaw, Poland
| | - Olga Płaza
- Psychiatric Clinic of the Faculty of Health Sciences, Medical University of Warsaw, 02-091 Warsaw, Poland
| | - Piotr Gałecki
- Department of Adult Psychiatry, Medical Univeristy of Lodz, 90-419 Lodz, Poland
| |
Collapse
|
3
|
Nowak A, Kutyła M, Kaczmarek J, Jaroszuk-Ściseł J, Jędryczka M. Differences in the Production of Extracellular Polymeric Substances (EPS) and Other Metabolites of Plenodomus ( Leptosphaeria) Infecting Winter Oilseed Rape ( Brassica napus L.). Metabolites 2023; 13:759. [PMID: 37367918 DOI: 10.3390/metabo13060759] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2023] [Revised: 06/12/2023] [Accepted: 06/14/2023] [Indexed: 06/28/2023] Open
Abstract
Species of the genus Plenodomus (Leptosphaeria) are phytopathogens of the Brassicaceae family, which includes oilseed rape. The spores of these fungi spread by airborne transmission, infect plants, and cause crop losses. The secondary metabolism of P. lingam and P. biglobosus was studied and compared, with the main focus being on the ability to produce Extracellular Polymeric Substances (EPS). In spite of the 1.5-2-fold faster growth rate of P. biglobosus on Czapek-Dox and other screening media, the average yield of EPS in this fungus was only 0.29 g/L, compared to that of P. lingam (0.43 g/L). In turn, P. biglobosus showed a higher capacity to synthesise IAA, i.e., 14 µg/mL, in contrast to <1.5 µg/mL produced by P. lingam. On the other hand, the P. lingam strains showed higher β-glucanase activity (350-400 mU/mL), compared to 50-100 mU/mL in P. biglobosus. Invertase levels were similar in both species (250 mU/mL). The positive correlation between invertase activity and EPS yield contrasted with the absence of a correlation of EPS with β-glucanase. Plenodomus neither solubilised phosphate nor used proteins from milk. All strains showed the ability to synthesise siderophores on CAS agar. P. biglobosus exhibited the highest efficiency of amylolytic and cellulolytic activity.
Collapse
Affiliation(s)
- Artur Nowak
- Department of Industrial and Environmental Microbiology, Institute of Biological Sciences, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka 19, 20-033 Lublin, Poland
| | - Mateusz Kutyła
- Department of Industrial and Environmental Microbiology, Institute of Biological Sciences, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka 19, 20-033 Lublin, Poland
| | - Joanna Kaczmarek
- Department of Pathogen Genetics and Plant Resistance, Institute of Plant Genetics, Polish Academy of Sciences, Strzeszyńska 34, 60-479 Poznań, Poland
| | - Jolanta Jaroszuk-Ściseł
- Department of Industrial and Environmental Microbiology, Institute of Biological Sciences, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka 19, 20-033 Lublin, Poland
| | - Małgorzata Jędryczka
- Department of Pathogen Genetics and Plant Resistance, Institute of Plant Genetics, Polish Academy of Sciences, Strzeszyńska 34, 60-479 Poznań, Poland
| |
Collapse
|
4
|
Nowak A, Wojtowicz M, Baranski K, Galczynska D, Daniluk J, Pluta D. The correlation of vitamin D level with body mass index in women with PCOS. Ginekol Pol 2023:VM/OJS/J/94129. [PMID: 37162141 DOI: 10.5603/gp.a2023.0037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2023] [Accepted: 03/09/2023] [Indexed: 05/11/2023] Open
Abstract
OBJECTIVES The aim of this study is to analyze correlation between vitamin D level and BMI in polycystic ovary syndrome (PCOS) women. MATERIAL AND METHODS The study group consisted of 311 patients with PCOS. Patients were categorized according to four phenotypes. All of the women participating in the study had their blood tested in the appropriate phase of the menstrual cycle and after proper preparation for the tests. The ultrasound examination and anthropometric measurements were performed. RESULTS Vitamin D concentration was assessed in all study subgroups. The majority of patients had vitamin D deficiency or insufficient level. Variables included in the study, such as level of vitamin D, low density lipoprotein (LDL), sex hormone binding globulin (SHBG), testosterone, androstenedione, Anti-Müllerian Hormone (AMH) and BMI were correlated. A negative correlation was observed with the the level of SHBG, vitamin D and AMH. Subsequently, positive correlations were shown with testosterone, LDL and free testosterone level. An analysis of the correlation between BMI and vitamin D concentration showed that in phenotype I of PCOS this correlation was statistically significant and in the remaining PCOS phenotypes the correlation was close to statistical significance. CONCLUSIONS Most PCOS patients have a deficiency or insufficient level of vitamin D. Women with PCOS have shown a significant negative correlation between BMI and SHBG serum level and between BMI and AMH level. A positive correlation exists between BMI and total and free testosterone and LDL. There is a negative correlation between BMI and vitamin D level in PCOS patients and in phenotype I this correlation was statistically significant.
Collapse
Affiliation(s)
- Artur Nowak
- Department of Gynecology and Obstetrics, Clinic of Gynecological Endocrinology, Medical University of Silesia, Katowice, Poland
| | - Mariusz Wojtowicz
- Department of Gynecological and Obstetrics, Women's and Child Health Center, Medical University of Silesia, Poland
| | - Kamil Baranski
- Department of Epidemiology, School of Medicine in Katowice, Medical University of Silesia in Katowice, Poland, Poland
| | - Dominika Galczynska
- Department of Gynecological Endocrinology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland, Poland
| | - Jakub Daniluk
- Students Scientific Association of Gynecological Endocrinology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
| | - Dagmara Pluta
- Department of Gynecological Endocrinology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland, Poland.
| |
Collapse
|
5
|
Nowak A, Boguslawski K. A configuration interaction correction on top of pair coupled cluster doubles. Phys Chem Chem Phys 2023; 25:7289-7301. [PMID: 36810525 DOI: 10.1039/d2cp05171k] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Numerous numerical studies have shown that geminal-based methods are a promising direction to model strongly correlated systems with low computational costs. Several strategies have been introduced to capture the missing dynamical correlation effects, which typically exploit a posteriori corrections to account for correlation effects associated with broken-pair states or inter-geminal correlations. In this article, we scrutinize the accuracy of the pair coupled cluster doubles (pCCD) method extended by configuration interaction (CI) theory. Specifically, we benchmark various CI models, including, at most double excitations against selected CC corrections as well as conventional single-reference CC methods. A simple Davidson correction is also tested. The accuracy of the proposed pCCD-CI approaches is assessed for challenging small model systems such as the N2 and F2 dimers and various di- and triatomic actinide-containing compounds. In general, the proposed CI methods considerably improve spectroscopic constants compared to the conventional CCSD approach, provided a Davidson correction is included in the theoretical model. At the same time, their accuracy lies between those of the linearized frozen pCCD and frozen pCCD variants.
Collapse
Affiliation(s)
- Artur Nowak
- Institute of Physics, Faculty of Physics, Astronomy and Informatics, Nicolaus Copernicus University in Toruń, Grudziadzka 5, 87-100 Toruń, Poland.
| | - Katharina Boguslawski
- Institute of Physics, Faculty of Physics, Astronomy and Informatics, Nicolaus Copernicus University in Toruń, Grudziadzka 5, 87-100 Toruń, Poland.
| |
Collapse
|
6
|
Majewska M, Wdowiak-Wróbel S, Marek-Kozaczuk M, Nowak A, Tyśkiewicz R. Cadmium-resistant Chryseobacterium sp. DEMBc1 strain: characteristics and potential to assist phytoremediation and promote plant growth. Environ Sci Pollut Res Int 2022; 29:83567-83579. [PMID: 35768711 DOI: 10.1007/s11356-022-21574-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/03/2022] [Accepted: 06/15/2022] [Indexed: 06/15/2023]
Abstract
The effectiveness of phytoremediation is closely related to the various interactions between pollutants, soil particles, rhizosphere microorganisms, and plants. Therefore, the object of current study was a cadmium-tolerant bacterium isolated from the rye rhizosphere, with a high degree of genetic similarity to the genus Chryseobacterium. Chryseobacterium sp. DEMBc1 was able to grow with 36 different BiologGN2 carbon sources and show the adaptation to stress factors such as Cd (100 μg ml-1), low temperature (8 °C), and salinity (2% NaCl). Furthermore, it was shown that DEMBc1 had the characteristics of plant growth-promoting microorganisms: it was able to produce ammonia, indole acetic acid, 1-aminocyclopropane-1-carboxylic acid deaminase, and siderophores, as well as solubilize Ca3(PO4)3. After inoculation with DEMBc1, a significant decrease in the concentration of Cd was observed in the roots of Festuca ovina grown in Cd-polluted soil, compared to the non-inoculated Cd-polluted soil. It was also noticed that DEMBc1 produced a large amount of extracellular polymeric substances that were significantly higher than the cellular biomass. These polymers can form a barrier to reduce the translocation of Cd from the growth medium to the plant roots. According to the current study, DEMBc1 has a stabilizing potential and can decrease the mobility of Cd in the F. ovina rhizosphere, bioaccumulate metals in plant tissues, and effectively improve the bioavailability of nutrients, especially Fe, N, and P in a polluted environments.
Collapse
Affiliation(s)
- Małgorzata Majewska
- Department of Industrial and Environmental Microbiology, Institute of Biological Sciences, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka St. 19, 20-033, Lublin, Poland.
| | - Sylwia Wdowiak-Wróbel
- Department of Genetic and Microbiology, Institute of Biological Sciences, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka St. 19, 20-033, Lublin, Poland
| | - Monika Marek-Kozaczuk
- Department of Genetic and Microbiology, Institute of Biological Sciences, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka St. 19, 20-033, Lublin, Poland
| | - Artur Nowak
- Department of Industrial and Environmental Microbiology, Institute of Biological Sciences, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka St. 19, 20-033, Lublin, Poland
| | - Renata Tyśkiewicz
- Analytical Laboratory, Łukasiewicz Research Network - New Chemical Syntheses Institute, Tysiąclecia Państwa Polskiego Ave. 13a, 24-110, Puławy, Poland
| |
Collapse
|
7
|
Keshwani D, Eyileten C, Wicik Z, Nowak A, Jakubik D, Simoes SN, Martins-Jr DC, Shahzadi A, Jarosz-Popek J, Wolska M, Siller-Matula J, Postula M. Thrombosis-related miR-16-5p predicts the disease severity in patients hospitalised for COVID-19. Eur Heart J 2022. [PMCID: PMC9619666 DOI: 10.1093/eurheartj/ehac544.3071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Introduction SARS-CoV-2 tropism for the ACE2 receptor, along with the multifaceted inflammatory reaction, is likely to drive the generalized hypercoagulable state seen in patients with COVID-19. Methodology Using the original bioinformatic workflow and network medicine approaches we reanalyzed four coronavirus-related expression datasets and performed co-expression analysis focused on thrombosis and ACE2 related genes. We identified microRNAs (miRNAs) which play role in ACE2-related thrombosis in coronavirus infection and further, we validated the expressions of those miRNAs in 79 hospitalized COVID-19 patients and 32 healthy volunteers by PCR and monitored miRNAs patterns during the acute phase of COVID-19, as well as the prognostic potential of these miRNAs as biomarkers. Results We identified EGFR, HSP90AA1, APP, TP53, PTEN, UBC, FN1, ELAVL1 and CALM1 as regulatory genes which could play a pivotal role in COVID-19 related thrombosis. We also found miR-16-5p, miR-27a-3p, Let-7b-5p and miR-155-5p as regulators in coagulation and thrombosis process. We observed in separate cohort of COVID-19 patients and healthy controls that (i) expression of miR-16-5p, miR-27a-3p and miR-155-5p increased during observation, compared to the baseline measurement; (ii) a low baseline miR-16-5p expression presents predictive utility in assessment of the hospital length of stay or death in follow-up as a composite endpoint (AUC: 0.810, 95% CI, 0.71–0.91, p<0.0001); (iii) low baseline expression of miR-16-5p and diabetes mellitus are independent predictors of increased length of stay or death according to a multivariate analysis (OR: 9.417; 95% CI, 2.647–33.506; p=0.0005 and OR: 6.257; 95% CI, 1.049–37.316; p=0.044, respectively). Conclusion This study enabled us to better characterize changes in gene expression and signaling pathways related to COVID-19 thrombosis. In this study we identified, characterized and validated miRNAs which could serve as novel, thrombosis-related biomarkers of the COVID-19, can be used for early stratification of patients and prediction of severity of infection development in an individual. Funding Acknowledgement Type of funding sources: Public Institution(s). Main funding source(s): Medical University of Warsaw
Collapse
Affiliation(s)
- D Keshwani
- Medical University of Warsaw, Department of Experimental and Clinical Pharmacology , Warsaw , Poland
| | - C Eyileten
- Medical University of Warsaw , Warsaw , Poland
| | - Z Wicik
- Medical University of Warsaw, Department of Experimental and Clinical Pharmacology , Warsaw , Poland
| | - A Nowak
- Medical University of Warsaw, Doctoral School , Warsaw , Poland
| | - D Jakubik
- Medical University of Warsaw, Department of Experimental and Clinical Pharmacology , Warsaw , Poland
| | - S N Simoes
- Faculty of Medicine of ABC, Center for Mathematics, Computing and Cognition , Santo Andre , Brazil
| | - D C Martins-Jr
- Faculty of Medicine of ABC, Center for Mathematics, Computing and Cognition , Santo Andre , Brazil
| | - A Shahzadi
- Istanbul University Cerrahpasa Faculty of Medicine, Department of Medical Pharmacology , Istanbul , Turkey
| | - J Jarosz-Popek
- Medical University of Warsaw, Doctoral School , Warsaw , Poland
| | - M Wolska
- Medical University of Warsaw, Doctoral School , Warsaw , Poland
| | | | - M Postula
- Medical University of Warsaw, Department of Experimental and Clinical Pharmacology , Warsaw , Poland
| |
Collapse
|
8
|
Eyileten C, Nowak A, Shahzadi A, Jarosz-Popek J, Jakubik D, Gasecka A, Van Der Pol E, Wolska M, Mirowska-Guzel M, Czlonkowska A, Postula M. Diagnostic ability of miR-19a and Let-7f along with platelet and leukocyte extracellular vesicles in acute ischemic stroke patients. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.3055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Ischemic stroke (IS) is one of the most frequent causes of death. Since miRNAs have been illustrated to play an important role in various processes through regulation of multiple genes, and platelet function, their utility as novel biomarkers should be determined.
Purpose
We aimed to analyze the circulating platelet-derived miR-19a-3p, miR-186-5p, Let-7f, platelet-extracellular vesicles (EVs), leukocyte-EVs, and endothelial-EVs levels 24-h and 7-days after IS as novel diagnostic and prognostic/predictive biomarkers in 28 acute IS and 35 control patients.
Methods
Blood samples of 28 patients diagnosed with acute IS with hyper platelet reactivity were collected 24-h and 7-days after stroke and 35 age- and gender-matched individuals free of stroke with multiple risk factors for cardiovascular disease. Platelet reactivity was assessed by AA-, TRAP-, ADP-induced platelet aggregometry. PlasmaRNA was extracted; quality RNA was assessed: fluorometric assay; RT-PCR for miRNAs expression measurement and flow-cytometry for EVs determination p<0.05.
Results
Patients with IS on day-1 had significantly higher platelet reactivity assessed by AA-induced platelet aggregometry compared to controls (p=0.001). Patients with normal platelet activation had significantly higher miR-186-5p expression levels compared to patients with HPR at day-1 acute-stroke (p=0.034). Seven days after acute stroke, expression levels of miR-186-5p significantly decreased in the same patients with normal platelet reactivity (p=0.036). Patients with HPR had significantly elevated platelet-EVs (CD62) concentration compared to patients with normal platelet reactivity at the day of 1 acute-stroke (p=0.012). Similarly, patients with HPR had significantly higher leukocyte-EVs (CD45) concentration compared to patients with normal platelet function at day-1 acute-stroke (p=0.002). Diagnostic values of baseline miRNAs and EVs were evaluated with receiver operating characteristic curve analysis. ROC curve showed that pooling the miR-19a-3p expressions, platelet-EVs, and leukocyte-EVs concentration yielded a higher AUC than the value of each individual biomarker as AUC was 0.893 (95% CI, 0.79–0.99). Patients with moderate stroke had significantly elevated miR-19a-3p expression levels compared with patients with minor stroke at the day of acute IS. AUC in ROC curve analysis was 0.867, (95% CI, 0.74–0.10) p=0.001.
Conclusions
Our analysis showed alteration of circulating miRNAs and EVs after IS. Combination of miR-19a-3p, Let-7f, platelet-EVs and leukocyte-EVs might have a diagnostic value for acute stroke and miR-19a-3p can predict the severity of stroke in IS patients.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): National Science Centre - Narodowe Centrum Nauki
Collapse
Affiliation(s)
- C Eyileten
- Medical University of Warsaw, Department of Experimental and Clinical Pharmacology , Warsaw , Poland
| | - A Nowak
- Medical University of Warsaw, Doctoral School , Warsaw , Poland
| | - A Shahzadi
- Istanbul University Cerrahpasa Faculty of Medicine , Istanbul , Turkey
| | - J Jarosz-Popek
- Medical University of Warsaw, Doctoral School , Warsaw , Poland
| | - D Jakubik
- Medical University of Warsaw, Department of Experimental and Clinical Pharmacology , Warsaw , Poland
| | - A Gasecka
- Medical University of Warsaw, Department of Cardiology , Warsaw , Poland
| | - E Van Der Pol
- Amsterdam University Medical Centre , Amsterdam , The Netherlands
| | - M Wolska
- Medical University of Warsaw, Doctoral School , Warsaw , Poland
| | - M Mirowska-Guzel
- Medical University of Warsaw, Department of Experimental and Clinical Pharmacology , Warsaw , Poland
| | - A Czlonkowska
- Medical University of Warsaw, Department of Experimental and Clinical Pharmacology , Warsaw , Poland
| | - M Postula
- Medical University of Warsaw, Department of Experimental and Clinical Pharmacology , Warsaw , Poland
| |
Collapse
|
9
|
Jakubik D, Eyileten C, Nowak A, Wolska M, Keshwani D, Jarosz-Popek J, De Rosa S, Mirowska-Guzel D, Siller-Matula J, Postula M. Circulating miRNAs as independent predictors of cardiovascular mortality in patients with type 2 diabetes mellitus. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
MicroRNAs (miRNAs, miR) are essential gene expression regulators involved in numerous biological processes and diseases including type 2 diabetes (DM).
Purpose
We aimed to determine the predictive value of selected circulating miRNAs for cardiovascular and all-cause mortality and their potential usefulness as biomarkers in DM patients.
Method
Two hundred fifty-two patients with diabetes were enrolled in the study. Among the patients included, 26 (10.3%) patients died during a median follow-up of 71 months (5.9 years). Plasma miR-191 and miR-16 expressions were assessed by quantitative real-time PCR and compared between the patients who survived and those who died.
Results
Patients who died from cardiovascular-related death had significantly higher expression of miR-191 and miR-16 as compared with patients who survived (p=0.003, p=0.001, respectively). The study population was divided into two subgroups by using ROC curve analysis for each miRNA, i.e., low or high value of single miRNAs. Kaplan Meier and Cox regression were performed for survival analysis. High expression levels of miRNAs were associated with cardiovascular mortality, when the models included one single miRNA and other covariates: miR-191 (HR = 4.793, 95% CI: 1.48–15.579; p=0.009) and miR-16 (HR = 4.66, 95% CI: 1.48–14.75; p=0.009). Furthermore, miRNAs expression between clopidogrel and the whole acetylsalicylic acid groups (i.e., 75 mg +150 mg), miR-191 expressions was significantly higher in the clopidogrel subgroup (p=0.010), whereas miR-16 did not differ (p=0.127).
Conclusion
To conclude, miR-191 and miR-16 expression are strong and independent predictors of cardiovascular and all-cause mortality in patients with T2DM. Moreover, miR-191 and miR-16 present significant interactions with antiplatelet treatment regimens and clinical outcomes.
Funding Acknowledgement
Type of funding sources: Public Institution(s). Main funding source(s): Medical University of Warsaw
Collapse
Affiliation(s)
- D Jakubik
- Medical University of Warsaw, Department of Experimental and Clinical Pharmacology , Warsaw , Poland
| | - C Eyileten
- Medical University of Warsaw, Department of Experimental and Clinical Pharmacology , Warsaw , Poland
| | - A Nowak
- Medical University of Warsaw, Doctoral School , Warsaw , Poland
| | - M Wolska
- Medical University of Warsaw, Doctoral School , Warsaw , Poland
| | - D Keshwani
- Medical University of Warsaw, Department of Experimental and Clinical Pharmacology , Warsaw , Poland
| | - J Jarosz-Popek
- Medical University of Warsaw, Doctoral School , Warsaw , Poland
| | - S De Rosa
- Magna Graecia University of Catanzaro , Catanzaro , Italy
| | - D Mirowska-Guzel
- Medical University of Warsaw, Department of Experimental and Clinical Pharmacology , Warsaw , Poland
| | - J Siller-Matula
- Medical University of Warsaw, Department of Experimental and Clinical Pharmacology , Warsaw , Poland
| | - M Postula
- Medical University of Warsaw, Department of Experimental and Clinical Pharmacology , Warsaw , Poland
| |
Collapse
|
10
|
Aliyeva F, Belkin M, Wussler D, Kozhuharov N, Mork C, Strebel I, Nowak A, Papachristou A, Breidthardt T, Mueller C. Prevalence, patient characteristics and outcome of hyponatremia in acute heart failure. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Hyponatremia is the most common electrolyte disturbance found in hospitalized patients. Previous studies have shown that low serum sodium levels at presentation are associated with increased mortality and morbidity in patients hospitalized with acute heart failure (AHF). However, given the complicated multifactorial origin of hyponatremia, the role of serum sodium level in risk stratification in patients with AHF is still largely unknown.
Purpose
To evaluate the prevalence and prognostic value of hyponatremia in patients presenting with AHF to the emergency department (ED).
Methods
Basics in Acute Shortness of Breath EvaLuation (BASEL V) was a prospective, multicenter, diagnostic study recruiting dyspneic patients at the ED. The final diagnosis of AHF was adjudicated by 2 independent physicians. Hyponatremia was defined as a serum sodium level of <135 mmol/l. The prognostic accuracy of hyponatremia in predicting all-cause mortality and a composite outcome of death and heart failure (HF) rehospitalization was quantified using multivariable adjusted Cox regression. Adjustments were made for the following variables: age, sex, history of ischemic heart disease, previous HF, infection as a trigger of AHF, systolic blood pressure, glomerular filtration rate and log-transformed N-terminal pro-B-type natriuretic peptide (NT-proBNP) at presentation. The incremental value of hyponatremia to the MEESSI-Score, a validated AHF risk score, was quantified using area under the curve (AUC) analyses.
Results
Among 1572 patients with AHF, 1499 patients were eligible for the main analysis, of whom 215 (14.3%) had hyponatremia, 1249 (83.3%) normonatremia and 35 (2.3%) hypernatremia at presentation. Of those with hyponatremia, 21 (9.8%) and 54 (25.1%) patients died, 27 (12.6%) and 79 (36.7%) patients experienced the composite outcome within 30 and 180 days, respectively. Multivariable adjusted hazard ratios (aHR) were 0.97 (95%-CI 0.94–1.01) and 0.97 (95%-CI 0.95–0.99) for mortality, 0.97 (95%-CI 0.94–1.00) and 0.98 (95%-CI 0.95–0.99) for the composite outcome within 30 and 180 days, respectively. The risk for mortality and a composite of all-cause mortality and HF rehospitalization within 180 days after presenting to the ED with AHF rose significantly with a lower sodium level at presentation. Each 1-unit decrease in sodium level [mmol/L] was associated with a 3% and 2.7% increase in the hazard rate of mortality (aHR 0.97, p=0.01) and the composite outcome (aHR 0.98, p=0.01), respectively. While in the 30-day analyses after multivariable adjustment sodium had no significant prognostic value. The already excellent predictive ability of the MEESSI-Score for 30-day mortality was not enhanced by sodium level (AUC 0.80 versus 0.80, p=0.834).
Conclusion
Hyponatremia at presentation is associated with a higher risk of 180-day mortality in patients with AHF. However, its role as an independent prognostic marker in risk stratification remains unclear.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Swiss National Science FoundationSchweizerische Herzstiftung
Collapse
Affiliation(s)
- F Aliyeva
- University Hospital Basel , Basel , Switzerland
| | - M Belkin
- University Hospital Basel , Basel , Switzerland
| | - D Wussler
- University Hospital Basel , Basel , Switzerland
| | | | - C Mork
- University Hospital Basel , Basel , Switzerland
| | - I Strebel
- University Hospital Basel , Basel , Switzerland
| | - A Nowak
- University Hospital Basel , Basel , Switzerland
| | | | | | - C Mueller
- University Hospital Basel , Basel , Switzerland
| |
Collapse
|
11
|
Blukacz Ł, Nowak A, Wójtowicz M, Krawczyk A, Franik G, Madej P, Pluta D, Kowalczyk K, Żorniak M. Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Polycystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ Sequence. Biomedicines 2022; 10:biomedicines10092193. [PMID: 36140294 PMCID: PMC9496340 DOI: 10.3390/biomedicines10092193] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2022] [Revised: 08/26/2022] [Accepted: 08/29/2022] [Indexed: 11/16/2022] Open
Abstract
The coexistence of polycystic ovary syndrome (PCOS) and liver steatosis has been studied for years. The gold standards for the diagnosis of liver steatosis are liver biopsy and magnetic resonance imaging (MRI), which are invasive and expensive methods. The main aim of this study is to check the usefulness of lipid accumulation product (LAP) and free androgen index (FAI) in the diagnosis of liver steatosis. The Ideal IQ MRI was performed in 49 women with PCOS phenotype A to assess the degree of liver steatosis, which was expressed with the proton density fat fraction (PDFF). Anthropometric examination and laboratory tests were performed, and the LAP and FAI were calculated. The correlation between MRI results and LAP, FAI, and one of the FAI components, sex hormone binding globulin (SHBG), was checked using statistical tests. There is a statistically significant correlation between PDFF and LAP and also between PDFF and FAI. LAP = 70.25 and FAI = 5.05 were established as cut-offs to diagnose liver steatosis. The SHBG is not a statistically significant parameter to predict liver steatosis. The study showed that especially LAP, but also FAI, can be used to predict liver steatosis with high specificity and sensitivity.
Collapse
Affiliation(s)
- Łukasz Blukacz
- Department of Gynecological Endocrinology, School of Medicine in Katowice, Medical University of Silesia, 40-752 Katowice, Poland
| | - Artur Nowak
- Gynecological and Obstetrician Polyclinic, 15-435 Białystok, Poland
| | - Mariusz Wójtowicz
- Department of Gynecological and Obstetrics, Women’s and Child Health Center, Medical University of Silesia, 41-803 Zabrze, Poland
| | - Angelika Krawczyk
- Student Scientific Association of Gynecological Endocrinology, School of Medicine in Katowice, Medical University of Silesia, 40-752 Katowice, Poland
- Correspondence:
| | - Grzegorz Franik
- Department of Gynecological Endocrinology, School of Medicine in Katowice, Medical University of Silesia, 40-752 Katowice, Poland
| | - Paweł Madej
- Department of Gynecological Endocrinology, School of Medicine in Katowice, Medical University of Silesia, 40-752 Katowice, Poland
| | - Dagmara Pluta
- Department of Gynecological Endocrinology, School of Medicine in Katowice, Medical University of Silesia, 40-752 Katowice, Poland
| | - Karolina Kowalczyk
- Department of Gynecological Endocrinology, School of Medicine in Katowice, Medical University of Silesia, 40-752 Katowice, Poland
| | - Michał Żorniak
- Department of Gastroenterological Oncology, The Maria Sklodowska-Curie National Institute of Oncology, 02-781 Warsaw, Poland
- Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland
| |
Collapse
|
12
|
Rovers S, Merlin C, Fisher S, Nowak A, Pauwels P, Lardon F, van Meerbeeck J, Smits E, Marcq E. EP07.01-024 Preclinical Investigation of Immune Checkpoint Blockade and Anti-Angiogenic Therapy in Malignant Pleural Mesothelioma. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
13
|
Hanaka A, Nowak A, Ozimek E, Dresler S, Plak A, Sujak A, Reszczyńska E, Strzemski M. Effect of copper stress on Phaseolus coccineus in the presence of exogenous methyl jasmonate and/or Serratia plymuthica from the Spitsbergen soil. J Hazard Mater 2022; 436:129232. [PMID: 35739752 DOI: 10.1016/j.jhazmat.2022.129232] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/28/2022] [Revised: 05/13/2022] [Accepted: 05/23/2022] [Indexed: 06/15/2023]
Abstract
Copper stress in the presence of exogenous methyl jasmonate and Serratia plymuthica in a complete trifactorial design with copper (0, 50 µM), methyl jasmonate (0, 1, 10 µM) and Serratia plymuthica (without and with inoculation) was studied on the physiological parameters of Phaseolus coccineus. Copper application reduced biomass and allantoin content, but increased chlorophyll and carotenoids contents as well as catalase and peroxidases activities. Jasmonate did not modify biomass and organic acids levels under copper treatment, but additional inoculation elevated biomass and content of tartrate, malate and succinate. Jasmonate used alone or in combination with bacteria increased superoxide dismutase activity in copper application. With copper, allantoin content elevated at lower jasmonate concentration, but with additional inoculation - at higher jasmonate concentration. Under copper stress, inoculation resulted in higher accumulation of tartrate, malate and citrate contents in roots, which corresponded with lower allantoin concentration in roots. Combined with copper, inoculation reduced catalase and guaiacol peroxidase activities, whereas organic acids content was higher. Under metal stress, with bacteria, jasmonate reduced phenolics content, elevated superoxide dismutase and guaiacol peroxidase activities. The data indicate that jasmonate and S. plymuthica affected most physiological parameters of P. coccineus grown with copper and revealed some effect on biomass.
Collapse
Affiliation(s)
- Agnieszka Hanaka
- Department of Plant Physiology and Biophysics, Institute of Biological Sciences, Faculty of Biology and Biotechnology, Maria Curie-Sklodowska University, Akademicka 19 Street, 20-033 Lublin, Poland.
| | - Artur Nowak
- Department of Industrial and Environmental Microbiology, Institute of Biological Sciences, Faculty of Biology and Biotechnology, Maria Curie-Sklodowska University, Akademicka 19 Street, 20-033 Lublin, Poland.
| | - Ewa Ozimek
- Department of Industrial and Environmental Microbiology, Institute of Biological Sciences, Faculty of Biology and Biotechnology, Maria Curie-Sklodowska University, Akademicka 19 Street, 20-033 Lublin, Poland.
| | - Sławomir Dresler
- Department of Plant Physiology and Biophysics, Institute of Biological Sciences, Faculty of Biology and Biotechnology, Maria Curie-Sklodowska University, Akademicka 19 Street, 20-033 Lublin, Poland; Department of Analytical Chemistry, Medical University of Lublin, Chodźki 4a, 20-093, Lublin, Poland.
| | - Andrzej Plak
- Institute of Earth and Environmental Sciences, Maria Curie-Sklodowska University, Kraśnicka 2d Avenue, 20-718 Lublin, Poland.
| | - Agnieszka Sujak
- Department of Biosystems Engineering, Faculty of Environmental and Mechanical Engineering, Poznań University of Life Sciences, Wojska Polskiego 50 Street, 60-627 Poznań, Poland.
| | - Emilia Reszczyńska
- Department of Plant Physiology and Biophysics, Institute of Biological Sciences, Faculty of Biology and Biotechnology, Maria Curie-Sklodowska University, Akademicka 19 Street, 20-033 Lublin, Poland.
| | - Maciej Strzemski
- Department of Analytical Chemistry, Medical University of Lublin, Chodźki 4a, 20-093, Lublin, Poland.
| |
Collapse
|
14
|
El Mikati IK, Khabsa J, Harb T, Khamis M, Agarwal A, Pardo-Hernandez H, Farran S, Khamis AM, El Zein O, El-Khoury R, Schünemann HJ, Akl EA, Alonso-Coello P, Alper BS, Amer YS, Arayssi T, Barker JM, Bouakl I, Boutron I, Brignardello-Petersen R, Carandang K, Chang S, Chen Y, Cuker A, El-Jardali F, Florez I, Ford N, Grove J, Guyatt GH, Hazlewood GS, Kredo T, Lamontagne F, Langendam MW, Lewin S, Macdonald H, McFarlane E, Meerpohl J, Munn Z, Murad MH, Mustafa RA, Neumann I, Nieuwlaat R, Nowak A, Pardo JP, Qaseem A, Rada G, Righini M, Rochwerg B, Rojas-Reyes MX, Siegal D, Siemieniuk R, Singh JA, Skoetz N, Sultan S, Synnot A, Tugwell P, Turner A, Turner T, Venkatachalam S, Welch V, Wiercioch W. A Framework for the Development of Living Practice Guidelines in Health Care. Ann Intern Med 2022; 175:1154-1160. [PMID: 35785533 DOI: 10.7326/m22-0514] [Citation(s) in RCA: 32] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/05/2023] Open
Abstract
BACKGROUND Living practice guidelines are increasingly being used to ensure that recommendations are responsive to rapidly emerging evidence. OBJECTIVE To develop a framework that characterizes the processes of development of living practice guidelines in health care. DESIGN First, 3 background reviews were conducted: a scoping review of methods papers, a review of handbooks of guideline-producing organizations, and an analytic review of selected living practice guidelines. Second, the core team drafted the first version of the framework. Finally, the core team refined the framework through an online survey and online discussions with a multidisciplinary international group of stakeholders. SETTING International. PARTICIPANTS Multidisciplinary group of 51 persons who have experience with guidelines. MEASUREMENTS Not applicable. RESULTS A major principle of the framework is that the unit of update in a living guideline is the individual recommendation. In addition to providing definitions, the framework addresses several processes. The planning process should address the organization's adoption of the living methodology as well as each specific guideline project. The production process consists of initiation, maintenance, and retirement phases. The reporting should cover the evidence surveillance time stamp, the outcome of reassessment of the body of evidence (when applicable), and the outcome of revisiting a recommendation (when applicable). The dissemination process may necessitate the use of different venues, including one for formal publication. LIMITATION This study does not provide detailed or practical guidance for how the described concepts would be best implemented. CONCLUSION The framework will help guideline developers in planning, producing, reporting, and disseminating living guideline projects. It will also help research methodologists study the processes of living guidelines. PRIMARY FUNDING SOURCE None.
Collapse
Affiliation(s)
- Ibrahim K El Mikati
- Clinical Research Institute, American University of Beirut, Beirut, Lebanon (I.K.M., J.K.)
| | - Joanne Khabsa
- Clinical Research Institute, American University of Beirut, Beirut, Lebanon (I.K.M., J.K.)
| | - Tarek Harb
- Faculty of Medicine, American University of Beirut, Beirut, Lebanon (T.H.)
| | - Mohamed Khamis
- Emergency Medicine Department, American University of Beirut, Beirut, Lebanon (M.K.)
| | - Arnav Agarwal
- Department of Medicine and Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada, and MAGIC Evidence Ecosystem Foundation, Oslo, Norway (A.A.)
| | - Hector Pardo-Hernandez
- Iberoamerican Cochrane Centre, Sant Pau Biomedical Research Institute, Barcelona, and CIBER Epidemiología y Salud Pública, Madrid, Spain (H.P.)
| | - Sarah Farran
- Clinical Pathology Department, American University of Beirut, Beirut, Lebanon (S.F.)
| | - Assem M Khamis
- Wolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, United Kingdom (A.M.K.)
| | - Ola El Zein
- Saab Medical Library, American University of Beirut, Beirut, Lebanon (O.E.)
| | - Rayane El-Khoury
- Infectious Disease Epidemiology Group and World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar (R.E.)
| | - Holger J Schünemann
- Department of Medicine and Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada (H.J.S.)
| | - Elie A Akl
- Clinical Research Institute, American University of Beirut, Beirut, Lebanon, and Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada (E.A.A.)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Krawczyk A, Kretek A, Pluta D, Nowak A, Madej P. Non-obvious diagnosis and breast development in pure gonadal dysgenesis. Ginekol Pol 2022; 93:519-520. [DOI: 10.5603/gp.a2022.0029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2022] [Accepted: 04/04/2022] [Indexed: 11/25/2022] Open
|
16
|
Patil S, Linge A, Hiepe H, Grosser M, Lohaus F, Gudziol V, Nowak A, Tinhofer I, Budach V, Guberina M, Stuschke M, Balermpas P, Rödel C, Schäfer H, Grosu A, Abdollahi A, Debus J, Belka C, Pigorsch S, Combs S, Boeke S, Zips D, Baumann M, Krause M, Löck S. MO-0139 PORT-C improves LRC in a subset of patients with intermediate-risk HNSCC: A matched pair analysis. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02299-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
17
|
Tyśkiewicz R, Nowak A, Ozimek E, Jaroszuk-Ściseł J. Trichoderma: The Current Status of Its Application in Agriculture for the Biocontrol of Fungal Phytopathogens and Stimulation of Plant Growth. Int J Mol Sci 2022; 23:2329. [PMID: 35216444 PMCID: PMC8875981 DOI: 10.3390/ijms23042329] [Citation(s) in RCA: 66] [Impact Index Per Article: 33.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2022] [Revised: 02/13/2022] [Accepted: 02/18/2022] [Indexed: 02/06/2023] Open
Abstract
Rhizosphere filamentous fungi of the genus Trichoderma, a dominant component of various soil ecosystem mycobiomes, are characterized by the ability to colonize plant roots. Detailed knowledge of the properties of Trichoderma, including metabolic activity and the type of interaction with plants and other microorganisms, can ensure its effective use in agriculture. The growing interest in the application of Trichoderma results from their direct and indirect biocontrol potential against a wide range of soil phytopathogens. They act through various complex mechanisms, such as mycoparasitism, the degradation of pathogen cell walls, competition for nutrients and space, and induction of plant resistance. With the constant exposure of plants to a variety of pathogens, especially filamentous fungi, and the increased resistance of pathogens to chemical pesticides, the main challenge is to develop biological protection alternatives. Among non-pathogenic microorganisms, Trichoderma seems to be the best candidate for use in green technologies due to its wide biofertilization and biostimulatory potential. Most of the species from the genus Trichoderma belong to the plant growth-promoting fungi that produce phytohormones and the 1-aminocyclopropane-1-carboxylate (ACC) deaminase enzyme. In the present review, the current status of Trichoderma is gathered, which is especially relevant in plant growth stimulation and the biocontrol of fungal phytopathogens.
Collapse
Affiliation(s)
- Renata Tyśkiewicz
- Analytical Laboratory, Łukasiewicz Research Network–New Chemical Syntheses Institute, Aleja Tysiąclecia Państwa Polskiego 13a, 24-110 Puławy, Poland
| | - Artur Nowak
- Department of Industrial and Environmental Microbiology, Faculty of Biology and Biotechnology, Institute of Biological Science, Maria-Curie Skłodowska University, Akademicka 19, 20-033 Lublin, Poland; (E.O.); (J.J.-Ś.)
| | - Ewa Ozimek
- Department of Industrial and Environmental Microbiology, Faculty of Biology and Biotechnology, Institute of Biological Science, Maria-Curie Skłodowska University, Akademicka 19, 20-033 Lublin, Poland; (E.O.); (J.J.-Ś.)
| | - Jolanta Jaroszuk-Ściseł
- Department of Industrial and Environmental Microbiology, Faculty of Biology and Biotechnology, Institute of Biological Science, Maria-Curie Skłodowska University, Akademicka 19, 20-033 Lublin, Poland; (E.O.); (J.J.-Ś.)
| |
Collapse
|
18
|
Piggott T, Nowak A, Brignardello-Petersen R, Cooke GS, Huttner B, Schünemann HJ, Persaud N, Magrini N, Moja L. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO. BMJ Open 2022; 12:e053349. [PMID: 35144950 PMCID: PMC8845216 DOI: 10.1136/bmjopen-2021-053349] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVES Examining the availability of essential medicines is a necessary step to monitor country-level progress towards universal health coverage. We compared the 2017 essential medicine lists (EML) of 137 countries to the WHO Model List to assess differences by drug class and country setting. METHODS We extracted all medicines prioritised at country level from most recently available national EMLs and compared each national EML with the 2017 WHO Model List of Essential Medicines (MLEM) as the reference standard. We assess EMLs by WHO region and for different types of medicine subgroups (eg, cancer, anti-infectives, cardiac, psychiatric and anaesthesia medicines) using within second-level anatomical therapeutic class (ATC) drug classes of the ATC Index. RESULTS We included 406 medicines from WHO's 2017 MLEM to compare to 137 concurrent national EMLs. We found a median of 315 (range from 44 to 983) medicines listed on national EMLs. The global median F1 score was 0.59 (IQR 0.47-0.70, maximum possible score indicating alignment with MLEM is 1). The F1 score was the highest (ie, most similar to MLEM) in the South-East Asia region and the lowest in the European region (ie, most dissimilar to MLEM). The F1 score was highest for stomatological preparations (median: 1.00), gynaecological-anti-infectives and antiseptics (median: 1.00), and medicated dressings (median: 1.00), and lowest for 9 anatomical or pharmacological groups (median: 0.00, eg, treatments for bone diseases, digestive enzymes). CONCLUSIONS Most countries are expected to improve their national health coverage by 2030 offering access to essential medicines, but our results revealed substantial gaps in selection of medicines at the national level compared with those recommended by WHO. It is crucial that governments consider investing in those effective medicines that are now neglected and continue monitoring progress towards essential medicine access as part of universal health coverage.
Collapse
Affiliation(s)
- Thomas Piggott
- Department of Health Research Methods, Evidence & Impact, McMaster University, Hamilton, Ontario, Canada
| | | | | | - Graham S Cooke
- Department of Infectious Disease, Imperial College London, London, UK
| | - Benedikt Huttner
- Department of Health Product Policy and Standards, World Health Organization, Geneva, Switzerland
| | - Holger J Schünemann
- Department of Health Research Methods, Evidence & Impact, McMaster University, Hamilton, Ontario, Canada
| | - Nav Persaud
- Department of Family and Community Medicine, St Michael's Hospital, Toronto, Ontario, Canada
| | | | - Lorenzo Moja
- Department of Health Product Policy and Standards, World Health Organization, Geneva, Switzerland
| |
Collapse
|
19
|
Siebenhüner K, Blaser J, Nowak A, Cheetham M, Mueller BU, Battegay E, Beeler PE. Comorbidities Associated with Worse Outcomes Among Inpatients Admitted for Acute Gastrointestinal Bleeding. Dig Dis Sci 2022; 67:3938-3947. [PMID: 34365536 PMCID: PMC8349143 DOI: 10.1007/s10620-021-07197-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/27/2020] [Accepted: 07/25/2021] [Indexed: 12/17/2022]
Abstract
BACKGROUND Multimorbidity increases healthcare resource utilization. Little is known on specific comorbidity combinations. AIMS To identify comorbidities associated with increased resource utilization among inpatients admitted for gastrointestinal bleeding (GIB). METHODS This retrospective cross-sectional study, 1/2010-5/2018 at the University Hospital Zurich, Switzerland, analyzed electronic health records of patients with upper (UGIB) and lower (LGIB) GIB, focusing on length of stay (LOS) and 30-day readmissions for resource use and clinical outcomes, investigated by multivariable regression adjusted for antithrombotics. RESULTS Of 1101 patients, 791 had UGIB and 310 LGIB, most often melena and bleeding diverticula, respectively. In UGIB, thromboembolic events showed a trend toward 27% increased LOS (1.27; 95% confidence interval [CI] 1.00-1.61), antithrombotics independently associated with 46% increased LOS (1.46; 95% CI 1.32-1.62). Cancer (odds ratio [OR] 2.86; 95% CI 1.68-4.88) independently associated with 30-day readmissions, anemia showed a trend (OR 1.68; 95% CI 1.00-2.84). In LGIB, none of the investigated comorbidities associated with increased LOS, but antithrombotics independently associated with 25% increased LOS (1.25; 95% CI 1.07-1.46). Atrial fibrillation/flutter (OR 2.69; 95% CI 1.06-6.82) and cancer (OR 4.76; 95% CI 1.40-16.20) associated strongly with 30-day readmissions. CONCLUSIONS In both groups, cancer associated with 30-day readmissions, antithrombotics with increased LOS. Thromboembolic events and anemia showed clinically important trends in UGIB. Atrial fibrillation/flutter associated with 30-day readmissions in LGIB. Prospective studies are needed to investigate these complex multimorbid populations and establish appropriate guidelines.
Collapse
Affiliation(s)
- K. Siebenhüner
- Institute of Epidemiology, Biostatistics and Prevention, University of Zurich, Hirschengraben 84, 8001 Zurich, Switzerland ,Department of Internal Medicine, University Hospital of Zurich, Zurich, Switzerland ,Centre of Competence Multimorbidity, University of Zurich, Zurich, Switzerland ,Department of Internal Medicine, University Hospital Zurich and University of Zurich, Zurich, Switzerland
| | - J. Blaser
- Directorate of Research and Education, University Hospital of Zurich, Zurich, Switzerland
| | - A. Nowak
- Department of Endocrinology and Clinical Nutrition, University Hospital Zurich and University of Zurich, Zurich, Switzerland ,Department of Internal Medicine, Psychiatry University Hospital Zurich, Zurich, Switzerland
| | - M. Cheetham
- Department of Internal Medicine, University Hospital Zurich and University of Zurich, Zurich, Switzerland
| | - B. U. Mueller
- Department of Internal Medicine, University Hospital Zurich and University of Zurich, Zurich, Switzerland
| | - E. Battegay
- Department of Internal Medicine, University Hospital of Zurich, Zurich, Switzerland ,Centre of Competence Multimorbidity, University of Zurich, Zurich, Switzerland ,Department of Internal Medicine, University Hospital Zurich and University of Zurich, Zurich, Switzerland
| | - P. E. Beeler
- Institute of Epidemiology, Biostatistics and Prevention, University of Zurich, Hirschengraben 84, 8001 Zurich, Switzerland ,Department of Internal Medicine, University Hospital Zurich and University of Zurich, Zurich, Switzerland
| |
Collapse
|
20
|
Fryc K, Nowak A, Bartlewski PM, Murawski M. 153 Effects of ewe age on oocyte viability and timing of early embryo cleavage. Reprod Fertil Dev 2021; 34:314. [PMID: 35231361 DOI: 10.1071/rdv34n2ab153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Affiliation(s)
- K Fryc
- Department of Animal Nutrition and Biotechnology, and Fisheries, University of Agriculture in Krakow, Cracow, Poland
| | - A Nowak
- Department of Animal Reproduction, Anatomy and Genomics, University of Agriculture in Krakow, Cracow, Poland
| | - P M Bartlewski
- Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada
| | - M Murawski
- Department of Animal Nutrition and Biotechnology, and Fisheries, University of Agriculture in Krakow, Cracow, Poland
| |
Collapse
|
21
|
Wussler D, Bayes-Genis A, Belkin M, Strebel I, Kozhuharov N, Revuelta-Lopez E, Nowak A, Lupon J, Gualandro DM, Shrestha S, Breidthardt T, Nunez J, Mueller C. CA 125 in the diagnosis and risk stratification of acute heart failure. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1021] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Recent evidence confirms the elevation of CA 125 in non-tumor processes such as acute heart failure (AHF). However, the utility of this novel biomarker for diagnosis, prognosis, and therapy guidance in AHF remains unclear.
Purpose
To investigate the potential of CA 125 for diagnosis, prognosis and therapy guidance in unselected AHF patients presenting with acute dyspnea to the emergency department (ED).
Methods
We quantified CA 125 in a blinded fashion among patients presenting with acute dyspnea to the ED in a multicenter diagnostic study. Final diagnosis of AHF including AHF-phenotype was centrally adjudicated by two independent cardiologists. To further characterize CA 125's potential in AHF correlations with established biochemical and imaging markers were assessed. Diagnostic accuracy for AHF was quantified by the area under the receiver operating characteristic curve (AUC). All-cause mortality within 360 days was the prognostic endpoint.
Results
Among 470 patients eligible for this analysis, 268 (57.0%) had adjudicated AHF. CA 125 concentrations at presentation were significantly higher among AHF patients vs. patients with other final diagnoses (45.8 U/ml [interquartile range (IQR), 18.5–110.3] vs. 16.2 U/ml [IQR, 9.6–31.6], p<.001). Patients with worsening heart failure had significant higher CA 125 levels compared to other heart failure phenotypes (p=.018). There was a significant positive correlation of CA 125 and high-sensitivity cardiac troponin T and NTproBNP and a significant negative correlation of CA 125 and left ventricular ejection fraction (correlation coefficients 0.204, 0.220, −0.331, respectively; all ps<.001). CA 125's AUC for AHF was significantly lower compared to NTproBNP's in the overall population (0.72, 95% confidence interval (CI) 0.67–0.76 vs. 0.93, 95% CI 0.90–0.95, p<.001, Figure 1) and in predefined subgroups according to age, gender and renal function. Among 268 AHF patients, 84 (31.3%) died within 360 days of follow-up. CA 125 plasma concentrations above the median indicated increased risk of all-cause mortality (hazard ratio 2.06, 95% CI 1.31–3.24; p=.002, Figure 2). CA 125's prognostic accuracy for 360-days mortality was comparable with NT-proBNP's and high-sensitivity cardiac troponin T's. CA 125 did not independently predict all-cause mortality at 360 days when used in validated multivariable regression models and had no interactions with medical therapies at discharge.
Conclusion
CA 125 may aid physicians in the risk stratification and rapid triage of patients with suspected AHF.
Funding Acknowledgement
Type of funding sources: Foundation. Main funding source(s): Swiss National Science FoundationSwiss Heart Foundation Figure 1. ROC curve comparisonFigure 2. Kaplan-Meier curve 360 days mortality
Collapse
Affiliation(s)
- D Wussler
- University Hospital Basel, Department of Cardiology, Basel, Switzerland
| | - A Bayes-Genis
- Germans Trias i Pujol Hospital, Department of Cardiology, Badalona, Spain
| | - M Belkin
- University Hospital Basel, Department of Cardiology, Basel, Switzerland
| | - I Strebel
- University Hospital Basel, Department of Cardiology, Basel, Switzerland
| | - N Kozhuharov
- University Hospital Basel, Department of Cardiology, Basel, Switzerland
| | - E Revuelta-Lopez
- Germans Trias i Pujol Hospital, Servicio de Bioquimica, Badalona, Spain
| | - A Nowak
- University Hospital Zurich, Psychiatry, Zurich, Switzerland
| | - J Lupon
- Germans Trias i Pujol Hospital, Department of Cardiology, Badalona, Spain
| | - D M Gualandro
- University Hospital Basel, Department of Cardiology, Basel, Switzerland
| | - S Shrestha
- University Hospital Basel, Department of Cardiology, Basel, Switzerland
| | - T Breidthardt
- University Hospital Basel, Department of Internal Medicine, Basel, Switzerland
| | - J Nunez
- Hospital Clinico Universitario, Department of Cardiology, Valencia, Spain
| | - C Mueller
- University Hospital Basel, Department of Cardiology, Basel, Switzerland
| | | |
Collapse
|
22
|
Eyileten C, Jarosz-Popek J, Jakubik D, Gasecka A, Wolska M, Czajka P, Nowak A, Ufnal M, Dizdarevic A, Toma A, Lang I, Postula M, Siller-Matula JM. Increased symmetric dimethyl-arginine is a predictor factor of decreased platelet reactivity and increased bleeding risk in patients with acute coronary syndrome. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1382] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
One of the promising biomarkers in CVD are asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA), which are products of L-arginine methylation and are both involved in endothelial dysfunction. ADMA, SDMA and L-homoarginine, have emerged as biomarkers linked to cardiovascular outcomes [1].
Purpose
To investigate the association of SDMA with platelet reactivity and bleeding risk in patients with acute coronary syndrome (ACS) treated with potent P2Y12 inhibitors prasugrel and ticagrelor.
Methods
Our prospective observational study enrolled 292 patients with ACS undergoing percuteneus coronary intervention [2]. Plasma concentrations of SDMA were measured during the hospitalization for ACS. Impedance aggregometry was used. The primary study endpoint was the concentration of metabolites and platelet reactivity. The primary clinical outcome endpoint was the incidence of Thrombolysis in Myocardial Infarction (TIMI) bleeding events (major, minor and minimal). The efficacy endpoint was the composite of major adverse cardiac events (MACE: stent thrombosis, myocardial infarction, stroke and cardiac death).
Results
There was an inverse correlation between SDMA serum levels and platelet reactivity (r=−0.25; p<0.000). The ADP+PGE1-induced platelet reactivity was 33% lower among patients with the highest SDMA quartile (4th) as compared to those with the 1–3rd SDMA quartile (8 [0–29] vs 12 [0–126] U; p<0.001). The AA-induced platelet reactivity was 56% lower among patients with the highest SDMA quartile (4th) as compared to those with the 1–3rd SDMA quartile (4 [0–48] vs 9 [0–133]; p<0.001). In a multivariate model, the highest SDMA (4th) quartile was found to be an independent predictor of the lowest ADP+PGE1 and AA induced platelet aggregation (OR: 2.666, 95% CI [1.184–5.999], p=0.018).
Conclusions
Our study shows that high plasma concentration of SDMA, but not ADMA, is independently associated with low platelet reactivity to ADP and AA and is associated with major and minor bleeding events in patients with ACS on potent antiplatelet therapies. Therefore, SDMA might have a potential to be further evaluated as a blood biomarker for individualization of duration and potency of antiplatelet therapies in an ACS population at high risk of bleeding complications.
Acknowledgment
I-COMET research team
Funding Acknowledgement
Type of funding sources: None. Figure 1Table 1
Collapse
Affiliation(s)
- C Eyileten
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - J Jarosz-Popek
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - D Jakubik
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - A Gasecka
- Medical University of Warsaw, 1st Chair and Department of Cardiology, Warsaw, Poland
| | - M Wolska
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - P Czajka
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - A Nowak
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - M Ufnal
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - A Dizdarevic
- Medical University of Vienna, Department of Internal Medicine II, Division of Cardiology, Vienna, Austria
| | - A Toma
- Medical University of Vienna, Department of Internal Medicine II, Division of Cardiology, Vienna, Austria
| | - I Lang
- Medical University of Vienna, Department of Internal Medicine II, Division of Cardiology, Vienna, Austria
| | - M Postula
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - J M Siller-Matula
- Medical University of Vienna, Department of Internal Medicine II, Division of Cardiology, Vienna, Austria
| | | |
Collapse
|
23
|
Eyileten C, Wicik Z, Jakubik D, Jarosz-Popek J, Czajka P, Jezewski M, Wolska M, Fitas A, Nowak A, Gasecka A, De Rosa S, Postula M. MicroRNAs as disease specific diagnostic biomarkers for neoplastic aetiology-related and inflammatory-related pericardial fluid effusion. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1836] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background and aim
Malignant involvement of the pericardium is seen in 1 to 20 percent of autopsies in patients with cancer. The most common metastatic tumor involving the pericardium is lung cancer [1]. We aimed to distinguish the origin of the pericardial fluid effusion (i.e. pericarditis vs cancer) based on miRNAs expression in peripheral blood plasma.
Method
8 patients hospitalized for collection of pericardial fluid with pericardial effusion of neoplastic aetiology (lung cancer). Control group includes 8 patients with effusion of inflammatory aetiology. Plasma RNA was extracted by mirVANAPARISKit and quality of RNA was assessed by fluorometric assay. GEP analysis was performed using the Clariom D pico chips, analysed on the Affymetrix platform. Statistical analysis by TAC software. Additional analyses were performed in and R using Signal information obtained from the TAC output. We performed the following tests using log2 transformed data and all comparison groups (A-F). Additional FDR correction, logistic regression, Mann-whitney t-test was used depending of the variables. We calculated Area under the curve using ROCp R package. Scores were ranging from 0 to 1. Co-expression analysis to identify genes authentically expressed was performed using Spearman correlation (cutoff = 0.9, Rpval = 0.05). In order to identify the targets of DE miRNAs we used our wizbionet R package and previously developed pipelines [2,3]. We performed target screening using multimiR package, selecting top 20% predictions from all available databases.
Results
We analyzed targets for all mature versions, and if DE miR was identified as pre-miR we generated -3p and -5p version for it. We also screened DisgeNet database for genes associated with cancer and pericarditis, we identified 2823 and 157 such genes. After identification of the targets of DE miRNAs we performed data aggregation, summarization and obtained information how many targets overall and targets associated with IS are regulated by each DE miRNA. Additionally we identified top targets regulated by the top miRNAs. MiR-5695, miR-4446-5p, miR-572, miR-3131 and miR-4784 were found the most significantly differentially expressed miRNAs in blood plasma for patients with malignancy compared to pericarditis. MiR-22-3p, miR-642a, miR-6771, miR-140-3p, and miR660-5p were found the most significantly differentially expressed miRNAs in pericardial fluid plasma for patients with malignancy compared to pericarditis. Importantly, miR-500b, miR-5188, miR-490, miR-24-3p, miR-383-3p were found the most promising differentially diagnostic biomarkers for malignancy and inflammatory-related pericardial fluid effusion.
Conclusions
For the first time our results indicate the differentially diagnostic power of miRNAs based on comparison of circulating in peripheral blood and pericardial fluid in patients having excessive pericardial fluid effusion due to different etiologies.
Funding Acknowledgement
Type of funding sources: None. Figure 1Figure 2
Collapse
Affiliation(s)
- C Eyileten
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - Z Wicik
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - D Jakubik
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - J Jarosz-Popek
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - P Czajka
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - M Jezewski
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - M Wolska
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - A Fitas
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - A Nowak
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - A Gasecka
- Medical University of Warsaw, 1st Chair and Department of Cardiology, Warsaw, Poland
| | - S De Rosa
- Magna Graecia University of Catanzaro, Division of Cardiology, Department of Medical and Surgical Sciences, Catanzaro, Italy
| | - M Postula
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | | |
Collapse
|
24
|
Eyileten C, Jarosz-Popek J, Jakubik D, Wolska M, Fitas A, Czajka P, Nowak A, Ufnal M, Postula M, Toma A, Lang I, Siller-Matula JM. High concentrations of plasma trimethylamine-n-oxide is associated with long-term cardiovascular mortality in patients with acute coronary syndrome. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Acute coronary syndrome (ACS) remains a leading cause of mortality worldwide [1]. Patients who experienced ACS are at high risk of future cardiovascular events and death [2–4]. Identification of reliable predictive tools could potentially improve the risk stratification [5]. Numerous studies revealed that intestinal microbial organisms (microbiota) and its metabolites, as TMAO (trimethylamine-N-oxide) may play a pathogenic role in a cardiovascular disease (CVD) and ACS [6]. Elevated concentration of circulating TMAO has been associated with increased risk of CVD and major adverse cardiac events (MACE), including myocardial infarction (MI), stroke, major bleeding and all-cause mortality [7].
Purpose
To investigate the association of liver metabolite TMAO with cardiovascular disease (CV)-related and all-cause mortality in patients with acute coronary syndrome (ACS) who underwent percutaneous coronary intervention.
Methods
Our prospective observational study enrolled 292 patients with ACS. Plasma concentrations of TMAO were measured during the hospitalization for ACS. Observation period lasted 7 years in the median. Adjusted Cox-regression analysis was used for prediction of mortality.
Results
ROC curve analysis revealed that increasing concentrations of TMAO levels assessed at the time point of ACS significantly predicted the risk of CV mortality (c-index=0.78, p<0.001). The cut-off value of >4 μmol/L, labeled as high TMAO level (23% of study population), provided the greatest sum of sensitivity (85%) and specificity (80%) for the prediction of CV mortality and was associated with a positive predictive value of 16% and a negative predictive value of 99%. A multivariate Cox regression model revealed that high TMAO level was a strong and independent predictor of CV death (HR=11.62, 95% CI: 2.26–59.67; p=0.003). High TMAO levels as compared with low TMAO levels were associated with the highest risk of CV death in a subpopulation of patients with diabetes mellitus (27.3% vs 2.6%; p=0.004). Although increasing TMAO levels were also significantly associated with all-cause mortality, their estimates for diagnostic accuracy were low.
Conclusions
High TMAO level is a strong and independent predictor of long-term CV mortality among patients presenting with ACS. TMAO concentration of 4 μmol/L may be a cut-off value for prognosis of ACS patients.
Funding Acknowledgement
Type of funding sources: None. Figure 1. Kaplan-Meier curvesTable 1
Collapse
Affiliation(s)
- C Eyileten
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - J Jarosz-Popek
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - D Jakubik
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - M Wolska
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - A Fitas
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - P Czajka
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - A Nowak
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - M Ufnal
- Medical University of Warsaw, Department of Experimental Physiology and Pathophysiology, Laboratory of Centre for Preclinical Rese, Warsaw, Poland
| | - M Postula
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - A Toma
- Medical University of Vienna, Department of Internal Medicine II, Division of Cardiology, Vienna, Austria
| | - I Lang
- Medical University of Vienna, Department of Internal Medicine II, Division of Cardiology, Vienna, Austria
| | - J M Siller-Matula
- Medical University of Vienna, Department of Internal Medicine II, Division of Cardiology, Vienna, Austria
| | | |
Collapse
|
25
|
Eyileten C, Wicik Z, Jarosz-Popek J, Czajka P, Fitas A, Wolska M, Nowak A, Jakubik D, Postula M, Pare G, De Rosa S, Czlonkowska A, Mirowska-Guzel D. Fingerprint of novel circulating microRNAs identify patients with stroke-embolic stroke of undetermined source. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.2061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Stroke is the second-most common cause of death worldwide. Circulating levels of selected microRNAs (miRNAs) were found to be modulated both in animal experimental models and in patients with stroke, opening up new avenues for the identification of more effective and specific biomarkers to identify and risk-stratify stroke patients. Aim of the present study is to identify all circulating miRNAs that are modulated in patients with stroke, to select specific miRNAs to be used as disease biomarkers to improve prognosis.
Methods
48 patients with stroke- ESUS were involved in the study. We have divided the patient groups based on patients who had a second stroke or TIA and did not have (safety vs safety control). Total RNA was extracted from plasma samples quality of extracted material was assessed using a fluorometric electrophoretic assay. MiRNA profiling was performed using the Affymetrix platform using. Statistical analysis was performed in TAC software. Additional analyses were performed in and R using Signal information obtained from the TAC output. We performed the following tests using log2 transformed data and all comparison groups (A-F). We performed additional FDR correction, logistic regression, Mann-whitney test t-test depending if variances were equal or differing. We calculated Area under the curve using ROCp R package. Scores were ranging from 0–1. Co-expression analysis to identify genes authentically expressed was performed using Spearman correlation (cutoff=0.9, Rpval=0.05). In order to identify the targets of DE miRNAs we used our wizbionet R package and previously developed pipelines [1,2]. We performed target screening using multimiR package, selecting top 20% predictions from all available databases.
Results
MiR-4786, miR-1205, miR-548ar-3p and miR-518e-3p were found the most differentially expressed miRNAs between the groups. So far, miR-4786 was studied only in patients with acute leukemia [3]. Several studies showed the importance of miR-1205 in cell carcinoma and ovarian cancer progression [4]. Moreover, so far only one study showed the regulation of miR-548ar-3p in breast cancer [5]. Finally only one study showed the alteration of miR-518e-3p in Parkinsons disease patients [6]. Besides, our enrichment analysis showed Interleukin-2 signaling pathway, Lipid and lipoprotein metabolism, BDNF signaling pathway, MAPK signaling pathway, Intellectual Disability, Alzheimer's Disease are significantly related to ESUS- patients.
Conclusions
Any of those miRNAs were never studied in stroke before, our results identified several novel circulating prognostic biomarkers miRNAs that are down- of up-regulated in ESUS-stroke patients (who had only one vs multiple stroke). Among those several miRNAs were identified that are known to play a role in the pathophysiology of neurovascular diseases, paving the way to a new class of smart pathophysiology-based biomarkers in stroke.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Polish National Science Center OPUS Figure 1Figure 2
Collapse
Affiliation(s)
- C Eyileten
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - Z Wicik
- Universidade Federal do ABC, Centro de Matemática, Computação e Cognição,, Sao Paulo, Brazil
| | - J Jarosz-Popek
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - P Czajka
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - A Fitas
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - M Wolska
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - A Nowak
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - D Jakubik
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - M Postula
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - G Pare
- McMaster University, Population Health Research Institute David Braley Cardiac, Vascular and Stroke Research Institute, Hamilton, Canada
| | - S De Rosa
- Magna Graecia University of Catanzaro, Division of Cardiology, Department of Medical and Surgical Sciences, Catanzaro, Italy
| | - A Czlonkowska
- Institute of Psychiatry and Neurology, 2nd Department of Neurology, Warsaw, Poland
| | - D Mirowska-Guzel
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | | |
Collapse
|
26
|
Eyileten C, Pordzik J, Jakubik D, Czajka P, Wolska M, Jarosz-Popek J, Fitas A, Nowak A, De Rosa S, Gasecka A, Cieslicka-Kaplon A, Siller-Matula J, Postula M. Increased Let-7e expression is associated with long-term all-cause mortality and antiplatelet treatment in patients with type 2 diabetes mellitus. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.2999] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
In the light of growing prevalence of type 2 diabetes mellitus (T2DM), efforts are made to discover novel biomarkers. MicroRNAs (miRNAs-miR) are non-coding RNAs used in various processes involved in regulating gene expression which play a role in platelet function.
Purpose
To analyze the ability of platelet-derived miRNAs in prediction of mortality and response to antiplatelet treatment among T2DM-patients.
Methods
252 diabetic subjects were enrolled and were receiving either acetylsalicylic acid (ASA) 75mg (65%) or 150 mg (15%) or clopidogrel (19%). Plasma miR-126, miR-223, miR-125a-3p and Let-7e expressions were assessed by qRT-PCR and compared between the patients who survived and those who died. Median observation time was 5.9 years. Adjusted Cox-regression analysis was used for prediction of mortality. Differential miRNAs expression due to different antiplatelet treatment was analyzed.
Results
ROC curve analysis revealed increasing concentrations of miR-126, Let-7e and miR-125a-3p levels had a diagnostic ability for prediction of long-term all-cause mortality (c-index=0.75, p<0.001; 0.72, p<0.001; 0.72, p=0.001, respectively). Multivariate Cox regression model revealed high miR-126 and Let-7e expressions which were strong and independent predictors of all-cause long-term mortality (HR=5.08, 95% CI: 1.92–13.43; p=0.001; HR=5.94, 95% CI: 1.98–17.79; p=0.001,respectively). After including all miRNAs into one multivariate Cox regression model, only Let-7e was predictive of future occurrence of long-term all-cause death (HR=7.83, 95% CI: 1.2–51.1; p=0.032). MiR-126, Let-7e and miR-223 expressions in the clopidogrel group were significantly higher than in the ASA group (p=0.014; p=0.013; p=0.028, respectively).
Conclusions
Let-7e expression is a strong and independent predictor of long-term all-cause mortality among patients with T2DM. MiR-223, miR-126 and Let-7e present significant interactions with antiplatelet treatment and clinical outcomes.
Funding Acknowledgement
Type of funding sources: None. Figure 1Table 1
Collapse
Affiliation(s)
- C Eyileten
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - J Pordzik
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - D Jakubik
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - P Czajka
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - M Wolska
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - J Jarosz-Popek
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - A Fitas
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - A Nowak
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - S De Rosa
- Magna Graecia University of Catanzaro, Division of Cardiology, Department of Medical and Surgical Sciences, Catanzaro, Italy
| | - A Gasecka
- Medical University of Warsaw, 1st Chair and Department of Cardiology, Warsaw, Poland
| | - A Cieslicka-Kaplon
- Medical University of Warsaw, 1st Chair and Department of Cardiology, Warsaw, Poland
| | - J Siller-Matula
- Medical University of Vienna, Department of Internal Medicine II, Division of Cardiology, Vienna, Austria
| | - M Postula
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | | |
Collapse
|
27
|
Belkin M, Wussler D, Michou E, Strebel I, Kozhuharov N, Sabti Z, Nowak A, Shrestha S, Lopez-Ayala P, Albus MB, Danier I, Simmen C, Diebold M, Breidthardt T, Mueller C. Prognostic value of self-reported subjective exercise capacity in patients with acute dyspnea. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Quantitative assessment of self-reported exercise capacity as provided by the Duke Activity Status Index (DASI) is a validated measure of exercise capacity in stable ambulatory patients.
Objectives
This study aimedto test whether the quantification of self-reported exercise capacityusing the DASI may aid physicians in the risk stratification of patients presenting with acute dyspnea to the emergency department (ED).
Methods
Basics in Acute Shortness of Breath EvaLuation (BASEL V) was a prospective cohort study recruiting dyspneic patients at the ED. The prognostic value and accuracy of theDASI assessed shortly after presentation were quantified using Cox regression analyses and the Area under the curve (AUC).
Results
Among 1019 patients eligible for this analysis 529 (51.9%) had an adjudicated final diagnosis of acute heart failure, 75 (7.4%) and 297 (29.1%) patients died within 90 and 720 days after presentation. Unadjusted hazard ratios (HR) and multivariable adjusted hazard ratios (aHR) for 90-day and 720-day mortality increased continuously from the fourth (best self-reported exercise capacity) to the first DASI-quartile (worst self-reported exercise capacity). For 720-day mortality in the first quartile theHR was 9.1 (95%-CI 5.5–14.9) (aHR 6.1 [95%-CI 3.7–10.1]), in the second quartile 6.4 (95%-CI 3.9–10.6) (aHR 4.4 [95%-CI 2.6–7.3]), while in the third quartile the HR was 3.2 (95%-CI 1.9–5.5) (aHR 2.4 [95%-CI 1.4–4.0]). The prognostic accuracy of the DASI was moderate-to-high and higher than that of B-type natriuretic peptide (BNP) and NT-proBNP (N-terminal pro-BNP) concentrations, e.g. for 720-day mortality prediction AUC 0.70 versus 0.64, p=0.020; 0.72 versus 0.68, p=0.074.
Conclusions
Quantification of self-reported subjective exercise capacityusing the DASI provides moderate-to-high prognostic accuracy in patients presenting with acute dyspnea to the ED and may aid physicians in further risk stratification.
Funding Acknowledgement
Type of funding sources: Public grant(s) – EU funding. Main funding source(s): European Union, the Swiss National Science Foundation. Duke Activity Status Index
Collapse
Affiliation(s)
- M Belkin
- University Hospital Basel, Basel, Switzerland
| | - D Wussler
- University Hospital Basel, Basel, Switzerland
| | - E Michou
- University Hospital Basel, Basel, Switzerland
| | - I Strebel
- University Hospital Basel, Basel, Switzerland
| | | | - Z Sabti
- University Hospital Basel, Basel, Switzerland
| | - A Nowak
- University Hospital Basel, Basel, Switzerland
| | - S Shrestha
- University Hospital Basel, Basel, Switzerland
| | | | - M B Albus
- University Hospital Basel, Basel, Switzerland
| | - I Danier
- University Hospital Basel, Basel, Switzerland
| | - C Simmen
- University Hospital Basel, Basel, Switzerland
| | - M Diebold
- University Hospital Basel, Basel, Switzerland
| | | | - C Mueller
- University Hospital Basel, Basel, Switzerland
| | | |
Collapse
|
28
|
Eyileten C, Fitas A, Jarosz-Popek J, Adem T, Jakubik D, Wolska M, Czajka P, Postula M, Nowak A, Gasecka A. MicroRNA-223 might be a predictive biomarker for major adverse cardiovascular events prognosis in patients undergoing transcatheter aortic valve implantation procedure. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0873] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Transcatheter aortic valve implantation (TAVI) is an emerging invasive therapeutic strategy for patients with severe aortic stenosis (AS) significantly enhancing not only quality-of-life measures but also improving short-and long-term survival rates.
Purpose
For these purposes we aimed to analyze correlation between expression levels of platelet-derived microRNAs in patients with heart failure (HF) due to AS who underwent TAVI procedure and assess their association with primary major adverse cardiac events (MACE) defined by all cause mortality and secondary MACE defined as cardiovascular mortality, ischemic stroke, and non-fatal myocardial infarction.
Methods
61 patients before and after the TAVI procedure were included. PlasmaRNA was extracted by mirVANA PARIS Kit and quality of RNA was assessed by fluorometric assay. GEP analysis was performed using the Clariom D pico chips, analyzed on the Affymetrix platform. RT-PCR was performed in order to validate the miRNAs in 61 patients by using the Taqman advanced protocol. MiRNA related to platelet function/antiplatelet treatment were chosen among those with the most relevant modulation between the groups. Wilcoxon test was performed for miRNAs comparison before and after TAVI. Calculations were performed using SPSS version 22.0, p<0.05 (IBM Corporation, Chicago, USA).
Results
We have found that miR-223, miR-125b and miR-125a were significantly increased in patients after the TAVI procedure. ROC analysis showed that increased miR-223 expression after the TAVI procedure might slightly have protective value against MACE outcome.
Conclusions
Our analysis showed alteration of circulating miRNAs after the TAVI procedure and miR-223 might have a predictive value for MACE prognosis in patients with HF due to AS who underwent TAVI procedure.
Acknowledgment
I-COMET research team
Funding Acknowledgement
Type of funding sources: None. Figure 1Figure 2
Collapse
Affiliation(s)
- C Eyileten
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - A Fitas
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - J Jarosz-Popek
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - T Adem
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - D Jakubik
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - M Wolska
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - P Czajka
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - M Postula
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - A Nowak
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - A Gasecka
- Medical University of Warsaw, 1st Chair and Department of Cardiology, Warsaw, Poland
| | | |
Collapse
|
29
|
Patil S, Linge A, Grosser M, Gudziol V, Nowak A, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Schäfer H, Grosu A, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs S, Mönnich D, Zips D, Baretton G, Baumann M, Krause M, Löck S. OC-0277 A 6-gene signature for loco-regional control prognosis in HNSCC patients treated by PORT-C. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)06827-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
30
|
Hajizadeh A, Lotfi T, Falzon D, Mertz D, Nieuwlaat R, Gebreselassie N, Jaramillo E, Korobitsyn A, Zignol M, Mirzayev F, Ismail N, Brozek J, Loeb M, Piggott T, Darzi A, Wang Q, Mahmood AS, Saroey P, Matthews M, Schünemann F, Dietl B, Nowak A, Kulesza K, Muti-Schünemann GEU, Bognanni A, Charide R, Akl EA, Kasaeva T, Schünemann HJ. Recommendation mapping of the World Health Organization's guidelines on tuberculosis: A new approach to digitizing and presenting recommendations. J Clin Epidemiol 2021; 134:138-149. [PMID: 33762142 PMCID: PMC8168829 DOI: 10.1016/j.jclinepi.2021.02.009] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2020] [Revised: 01/27/2021] [Accepted: 02/04/2021] [Indexed: 12/27/2022]
Abstract
OBJECTIVE Having up-to-date health policy recommendations accessible in one location is in high demand by guideline users. We developed an easy to navigate interactive approach to organize recommendations and applied it to tuberculosis (TB) guidelines of the World Health Organization (WHO). STUDY DESIGN We used a mixed-methods study design to develop a framework for recommendation mapping with seven key methodological considerations. We define a recommendation map as an online repository of recommendations from several guidelines on a condition, providing links to the underlying evidence and expert judgments that inform them, allowing users to filter and cross-tabulate the search results. We engaged guideline developers, users, and health software engineers in an iterative process to elaborate the WHO eTB recommendation map. RESULTS Applying the seven-step framework, we included 228 recommendations, linked to 103 guideline questions and organized the recommendation map according to key components of the health question, including the original recommendations and rationale (https://who.tuberculosis.recmap.org/). CONCLUSION The recommendation mapping framework provides the entire continuum of evidence mapping by framing recommendations within a guideline questions' population, interventions, and comparators domains. Recommendation maps should allow guideline developers to organize their work meaningfully, standardize the automated publication of guidelines through links to the GRADEpro guideline development tool, and increase their accessibility and usability.
Collapse
Affiliation(s)
- Anisa Hajizadeh
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada
| | - Tamara Lotfi
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada; World Health Organization Collaborating Center for Infectious Diseases, Research Methods and Recommendations, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton (ON), Canada
| | - Dennis Falzon
- Global TB Programme World Health Organization, Geneva, Switzerland, World Health Organization HQ, Avenue Appia 20, 1211 Geneva, Switzerland
| | - Dominik Mertz
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada; World Health Organization Collaborating Center for Infectious Diseases, Research Methods and Recommendations, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton (ON), Canada; Department of Medicine, McMaster University, Hamilton (ON), Canada
| | - Robby Nieuwlaat
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada; World Health Organization Collaborating Center for Infectious Diseases, Research Methods and Recommendations, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton (ON), Canada
| | - Nebiat Gebreselassie
- Global TB Programme World Health Organization, Geneva, Switzerland, World Health Organization HQ, Avenue Appia 20, 1211 Geneva, Switzerland
| | - Ernesto Jaramillo
- Global TB Programme World Health Organization, Geneva, Switzerland, World Health Organization HQ, Avenue Appia 20, 1211 Geneva, Switzerland
| | - Alexei Korobitsyn
- Global TB Programme World Health Organization, Geneva, Switzerland, World Health Organization HQ, Avenue Appia 20, 1211 Geneva, Switzerland
| | - Matteo Zignol
- Global TB Programme World Health Organization, Geneva, Switzerland, World Health Organization HQ, Avenue Appia 20, 1211 Geneva, Switzerland
| | - Fuad Mirzayev
- Global TB Programme World Health Organization, Geneva, Switzerland, World Health Organization HQ, Avenue Appia 20, 1211 Geneva, Switzerland
| | - Nazir Ismail
- Global TB Programme World Health Organization, Geneva, Switzerland, World Health Organization HQ, Avenue Appia 20, 1211 Geneva, Switzerland
| | - Jan Brozek
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada; World Health Organization Collaborating Center for Infectious Diseases, Research Methods and Recommendations, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton (ON), Canada; Department of Medicine, McMaster University, Hamilton (ON), Canada
| | - Mark Loeb
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada; World Health Organization Collaborating Center for Infectious Diseases, Research Methods and Recommendations, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton (ON), Canada; Department of Medicine, McMaster University, Hamilton (ON), Canada
| | - Thomas Piggott
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada
| | - Andrea Darzi
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada
| | - Qi Wang
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada
| | - Al Subhi Mahmood
- Department of Medicine, McMaster University, Hamilton (ON), Canada
| | - Praveen Saroey
- Department of Medicine, McMaster University, Hamilton (ON), Canada
| | - Micayla Matthews
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada
| | - Finn Schünemann
- University of Freiburg, Breisgau, Germany, Institut für Evidence in Medicine, Medical Center & Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - Bart Dietl
- Evidence Prime Inc, Toruńska 5, 30-056 Kraków, Poland
| | - Artur Nowak
- Evidence Prime Inc, Toruńska 5, 30-056 Kraków, Poland
| | - Kuba Kulesza
- Evidence Prime Inc, Toruńska 5, 30-056 Kraków, Poland
| | | | - Antonio Bognanni
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada
| | - Rana Charide
- American University of Beirut, American University of Beirut, Bliss Street, PO Box: 11-0236, Riad El Solh, Beirut 1107 2020, Lebanon
| | - Elie A Akl
- American University of Beirut, American University of Beirut, Bliss Street, PO Box: 11-0236, Riad El Solh, Beirut 1107 2020, Lebanon
| | - Tereza Kasaeva
- Global TB Programme World Health Organization, Geneva, Switzerland, World Health Organization HQ, Avenue Appia 20, 1211 Geneva, Switzerland
| | - Holger J Schünemann
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada; World Health Organization Collaborating Center for Infectious Diseases, Research Methods and Recommendations, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton (ON), Canada; Department of Medicine, McMaster University, Hamilton (ON), Canada.
| |
Collapse
|
31
|
Lorenzo JB, García-Blanco A, Moreno-Giménez A, Berga LC, Sahuquillo-Leal R, Nowak A, Hervás D, Diago V, Vento M. Does maternal age or related factors influence the appearance of psychopathology in children? Eur Psychiatry 2021. [PMCID: PMC9471647 DOI: 10.1192/j.eurpsy.2021.400] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
Introduction Maternal age and related factors, such as social vulnerability, are associated with neurodevelopmental and behavioral disorders in offspring. Objectives To examine the influence of maternal age and its related factors on the appearance of autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), alterations in executive functions and behavioral syndromes of the offspring. Methods A prospective study was conducted, consisting of 131 healthy pregnant women aged 20 to 41 years, recruited at 38 weeks’ gestation. Their offspring were followed up to 2 years after birth, when psychopatology was assessed. Maternal age and possible related factors were considered predictors. Bayesian ordinal regression models were performed for each outcome variable. Results Symptoms of ASD in children were associated with an older maternal age (OR = 0.188; 95% CI[1.062, 1.401]) and a lower educational level of the parents (OR = -0.879; 95% CI[0.202, 0.832]), meanwhile poor social support predicted most ADHD symptoms OR = -0.086; 95% CI[0.838, 1]) and executive dysfunctions OR = -0.661; 95% CI[0.313, 0.845]. Lower parental education predicted both externalizing and internalizing behavior. Conclusions Maternal age-related factors were the main predictors of neurodevelopmental disorders in offspring, rather than maternal age. The performance of prenatal interventions in pregnant women with advanced age and anxious depressive symptoms or adverse social situation, is crucial to reduce the risk of neurodevelopmental disorders in the offspring. Likewise, being able to carry out an early detection of childhood psychopathology would allow the implementation of resources that improve their long-term prognosis. Disclosure No significant relationships.
Collapse
|
32
|
Moreno-Martinez D, Aguiar P, Auray-Blais C, Beck M, Bichet DG, Burlina A, Cole D, Elliott P, Feldt-Rasmussen U, Feriozzi S, Fletcher J, Giugliani R, Jovanovic A, Kampmann C, Langeveld M, Lidove O, Linhart A, Mauer M, Moon JC, Muir A, Nowak A, Oliveira JP, Ortiz A, Pintos-Morell G, Politei J, Rozenfeld P, Schiffmann R, Svarstad E, Talbot AS, Thomas M, Tøndel C, Warnock D, West ML, Hughes DA. Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensus. Mol Genet Metab 2021; 132:234-243. [PMID: 33642210 DOI: 10.1016/j.ymgme.2021.02.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/14/2020] [Revised: 02/01/2021] [Accepted: 02/01/2021] [Indexed: 12/21/2022]
Abstract
BACKGROUND Recent years have witnessed a considerable increase in clinical trials of new investigational agents for Fabry disease (FD). Several trials investigating different agents are currently in progress; however, lack of standardisation results in challenges to interpretation and comparison. To facilitate the standardisation of investigational programs, we have developed a common framework for future clinical trials in FD. METHODS AND FINDINGS A broad consensus regarding clinical outcomes and ways to measure them was obtained via the Delphi methodology. 35 FD clinical experts from 4 continents, representing 3389 FD patients, participated in 3 rounds of Delphi procedure. The aim was to reach a consensus regarding clinical trial design, best treatment comparator, clinical outcomes, measurement of those clinical outcomes and inclusion and exclusion criteria. Consensus results of this initiative included: the selection of the adaptative clinical trial as the ideal study design and agalsidase beta as ideal comparator treatment due to its longstanding use in FD. Renal and cardiac outcomes, such as glomerular filtration rate, proteinuria and left ventricular mass index, were prioritised, whereas neurological outcomes including cerebrovascular and white matter lesions were dismissed as a primary or secondary outcome measure. Besides, there was a consensus regarding the importance of patient-related outcomes such as general quality of life, pain, and gastrointestinal symptoms. Also, unity about lysoGb3 and Gb3 tissue deposits as useful surrogate markers of the disease was obtained. The group recognised that cardiac T1 mapping still has potential but requires further development before its widespread introduction in clinical trials. Finally, patients with end-stage renal disease or renal transplant should be excluded unless a particular group for them is created inside the clinical trial. CONCLUSION This consensus will help to shape the future of clinical trials in FD. We note that the FDA has, coincidentally, recently published draft guidelines on clinical trials in FD and welcome this contribution.
Collapse
Affiliation(s)
- D Moreno-Martinez
- Lysosomal Storage Disorders Unit, Royal Free Hospital NHS Foundation Trust and University College London, London, UK
| | - P Aguiar
- Inborn Errors of Metabolism Reference Centre, North Lisbon Hospital Centre, Lisbon, Portugal
| | - C Auray-Blais
- Division of Medical Genetics, Department of Pediatrics, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada
| | - M Beck
- Institute of Human Genetics, University Medical Centre, University of Mainz, Mainz, Germany
| | - D G Bichet
- Unité de Recherche Clinique, Centre de Recherche et Service de Néphrologie, Hôpital du Sacré-Coeur de Montreal, Montreal, Quebec, Canada
| | - A Burlina
- Neurological Unit, St. Bassiano Hospital, Bassano del Grappa, Italy
| | - D Cole
- Department of Medical Biochemistry and Immunology, University Hospital of Wales, Cardiff, Wales, UK
| | - P Elliott
- Barts Cardiac Centre, University College London, London, UK
| | - U Feldt-Rasmussen
- Medical Endocrinology and Metabolism, Rigshospitalet, Copenhagen, Denmark
| | - S Feriozzi
- Division of Nephrology, Belcolle Hospital, Viterbo, Italy
| | - J Fletcher
- Genetics and Molecular Pathology, SA Pathology Women's and Children's Hospital, North Adelaide, Australia
| | - R Giugliani
- Medical Genetics Service, HCPA, Department of Genetics, UFRGS, Porto Alegre, Rio Grande do Sul, Brazil
| | - A Jovanovic
- Department of Endocrinology and Metabolic Medicine, Salford Royal NHS Foundation Trust, Salford, UK
| | - C Kampmann
- Centre for Paediatric and Adolescent Medicine, University Medical Centre, University of Mainz, Mainz, Germany
| | - M Langeveld
- Department of Endocrinology and Metabolism, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
| | - O Lidove
- Department of Internal Medicine, Université Paris 7, Hôpital Bichat Claude-Bernard, Paris, France
| | - A Linhart
- Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
| | - M Mauer
- Department of Paediatrics, University of Minnesota, Minneapolis, MN, United States
| | - J C Moon
- Cardiac Imaging Department, Barts Heart Centre, London, UK
| | - A Muir
- Belfast Heart Centre, Royal Victoria Hospital, Belfast, UK
| | - A Nowak
- Department of Endocrinology and Clinical Nutrition, University Hospital Zurich and University of Zurich, Zurich, Switzerland
| | - J P Oliveira
- Service of Medical Genetics, São João University Hospital Centre, Alameda Hernãni Monteiro, Porto, Portugal
| | - A Ortiz
- Fundación Jiménez Díaz (IIS-FJD) Área de Patología Cardiovascular, Renal e Hipertensión, Madrid, Spain
| | - G Pintos-Morell
- Rare and Metabolic Diseases Unit, Vall Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - J Politei
- Fundation for the Study of Neurometabolic Diseases, FESEN, Argentina
| | - P Rozenfeld
- Departamento de Ciencias Biológicas, CONICET, Facultad de Ciencias Exactas, IIFP, Universidad Nacional de La Plata, La Plata, Argentina
| | - R Schiffmann
- Institute of Metabolic Disease, Baylor Research Institute, Dallas, TX, USA
| | - E Svarstad
- Department of Clinical Medicine, University of Bergen and Haukeland University Hospital, Bergen, Norway
| | - A S Talbot
- Department of Nephrology, Royal Melbourne Hospital, Melbourne, Victoria, Australia
| | - M Thomas
- Department of Nephrology, Royal Perth Hospital, Perth, Western Australia, Australia
| | - C Tøndel
- Clinical Trials Unit, Haukeland University Hospital, Bergen, Norway
| | - D Warnock
- Division of Nephrology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - M L West
- Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
| | - D A Hughes
- Lysosomal Storage Disorders Unit, Royal Free Hospital NHS Foundation Trust and University College London, London, UK.
| |
Collapse
|
33
|
Kępczyńska-Nyk A, Kuryłowicz A, Nowak A, Bednarczuk T, Ambroziak U. Sexual function in women with androgen excess disorders: classic forms of congenital adrenal hyperplasia and polycystic ovary syndrome. J Endocrinol Invest 2021; 44:505-513. [PMID: 32557272 PMCID: PMC7878262 DOI: 10.1007/s40618-020-01332-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/03/2020] [Accepted: 06/08/2020] [Indexed: 11/25/2022]
Abstract
PURPOSE We compared the sexual function in women with classic forms of congenital adrenal hyperplasia (CAH) and polycystic ovary syndrome (PCOS) to find if the cause of androgen excess determines sexual functioning. METHODS Hundred and four women (21 with CAH, 63 with PCOS and 20 healthy controls) aged 18-40 years were included into the study. All participants completed a questionnaire regarding their sociodemographic background and underwent anthropometric and basic biochemical measurements. Plasma levels of total testosterone, androstenedione, and 17-hydroxyprogesterone were measured with immunoassay. To assess the sexual functions, the Female Sexual Function Index (FSFI) questionnaire was applied. RESULTS Apart from the higher physical activity in PCOS patients (P = 0.017), we found no significant sociodemographic differences between the studied groups. In clinical assessment, women with CAH had a lower incidence of acne (P = 0.006). Their plasma levels of 17OHP (P = 0.005) and insulin resistance index (P = 0.0248) were higher, while total testosterone (P = 0.0495) and glucose (P = 0.0061) was lower compared to the PCOS group. Significantly more women with CAH were homosexual (P = 0.003) and bisexual (P = 0.006). CAH group showed a lower total FSFI score (P = 0.0043) and lower scores in three domains: lubrication (P = 0.0131), sexual satisfaction (P = 0.0006), and dyspareunia (P < 0.0001). Higher physical activity was associated in all women with higher total FSFI score (P = 0.009) and scores in the domain of desire (P = 0.034) and sexual satisfaction (P = 0.01), while in CAH women apart from the total score (P = 0.03) and sexual satisfaction (P = 0.002) also in the domains of orgasm (P = 0.005), and pain (P = 0.03). CONCLUSIONS CAH women present more often homosexual and bisexual orientation, while their sexual functions are impaired compared to PCOS patients.
Collapse
Affiliation(s)
- A Kępczyńska-Nyk
- Department of Internal Medicine and Endocrinology, Warsaw Medical University, 1a Banacha street, 02-097, Warsaw, Poland
| | - A Kuryłowicz
- Department of Internal Medicine and Endocrinology, Warsaw Medical University, 1a Banacha street, 02-097, Warsaw, Poland.
- Department of Human Epigenetics, Mossakowski Medical Research Centre, Polish Academy of Sciences, 5 Pawińskiego street, 02-106, Warsaw, Poland.
| | - A Nowak
- Department of Internal Medicine and Endocrinology, Warsaw Medical University, 1a Banacha street, 02-097, Warsaw, Poland
| | - T Bednarczuk
- Department of Internal Medicine and Endocrinology, Warsaw Medical University, 1a Banacha street, 02-097, Warsaw, Poland
| | - U Ambroziak
- Department of Internal Medicine and Endocrinology, Warsaw Medical University, 1a Banacha street, 02-097, Warsaw, Poland
| |
Collapse
|
34
|
Tysarowski A, Seliga K, Gos A, Nowak A, Zub R, Jagielska B, Pluzanski A, Krzakowski M, Prochorec-Sobieszek M, Siedlecki J. P37.09 Comparison of 3 Different Methods for Determination of EGFR p.Thr790Met mutation in patients with NSCLC. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
35
|
Tysarowski A, Seliga K, Nowak A, Wagrodzki M, Gos A, Zub R, Olszewska K, Jagielska B, Knetki-Wróblewska M, Pluzanski A, Krzakowski M, Siedlecki J, Prochorec-Sobieszek M. P37.02 Identification of Gene Fusions and Mutations in Patients with NSCLC using two Diagnostic Approaches: Rapid qPCR and NGS. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.749] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
36
|
Nowak A, Legeza Ö, Boguslawski K. Orbital entanglement and correlation from pCCD-tailored coupled cluster wave functions. J Chem Phys 2021; 154:084111. [DOI: 10.1063/5.0038205] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Affiliation(s)
- Artur Nowak
- Institute of Physics, Faculty of Physics, Astronomy and Informatics, Nicolaus Copernicus University in Toruń, Grudziadzka 5, 87-100 Torun, Poland
| | - Örs Legeza
- Strongly Correlated Systems “Lendület" Research Group, Wigner Research Center for Physics, H-1525 Budapest, Hungary
| | - Katharina Boguslawski
- Institute of Physics, Faculty of Physics, Astronomy and Informatics, Nicolaus Copernicus University in Toruń, Grudziadzka 5, 87-100 Torun, Poland
| |
Collapse
|
37
|
Pena S, Fryc K, Murawski M, Nowak A, Kij B, Kochan J, Bartlewski P. 46 Use of time-lapse imaging technology to assess relationships of morphological and phototextural attributes of presumptive ovine zygotes and early embryos with their developmental competence invitro. Reprod Fertil Dev 2021. [DOI: 10.1071/rdv33n2ab46] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
The assessment of morphology and digital image opacity may provide valuable information on embryo viability because such traits are linked to embryonic gene expression, metabolism and ultrastructure. Time-lapse imaging has been used in research to monitor the dynamic nature of the developing pre-implantation embryo, which includes capturing alterations in various morphological parameters over time. The present study examined the effectiveness of time-lapse technology in assessing several morphometric and phototextural parameters for predicting the developmental potential of ovine embryos. The development of 37 long wool sheep embryos from IVF to the blastocyst stage was monitored and evaluated using Primo Vision time-lapse imaging technology. Image-Pro Plus software was then used to measure zona pellucida thickness, embryo diameter, cellular grey-scale pixel intensity and heterogeneity, and total area of the perivitelline space. A one-way analysis of variance (ANOVA) was done using SigmaPlot® 11.0 for all attributes at various time points during embryo development [i.e. presumptive zygote stage, t(0); first cleavage, t(2) or t(3); second cleavage, t(4) or t(6); and third cleavage, t(7) or t(8)]. Our results indicate that most parameters analysed did not differ among embryos varying in their developmental fate, with the exception of the perivitelline space area, which was greater (P<0.05) for non-dividing embryos than for future blastocysts at the presumptive zygote stage (4040±4137 vs. 857±642µm2, respectively; mean±s.d.). Consequently, the measurement of perivitelline space at t(0) could be used to predict developmental potential of invitro-produced ovine embryos, but further investigation is required.
Collapse
|
38
|
Scherpereel A, Antonia S, Bautista Y, Grossi F, Kowalski D, Zalcman G, Nowak A, Fujimoto N, Peters S, Tsao A, Mansfield A, Popat S, Sun X, Padilla B, Aanur P, Daumont M, Bennett B, McKenna M, Baas P. LBA1 First-line nivolumab (NIVO) plus ipilimumab (IPI) versus chemotherapy (chemo) for the treatment of unresectable malignant pleural mesothelioma (MPM): Patient-reported outcomes (PROs) from CheckMate 743. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.10.603] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
39
|
Postula M, Wicik Z, Eyileten C, Soplinska A, Czajka P, Nowak A, Jarosz-Popek J, Malek L. Not chronic exercise but acute exercise is related with increased cell survival, enhanced cell proliferation and decreased cell apoptosis. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Endurance training can be described as long-time activity characterized by high dynamic and low to high power and was proven beneficial in CVD prevention. Nevertheless, studies reported that excessive endurance training can act as double-edged sword inducing the inflammatory response and cell apoptosis. This negative effect can be the reason of exercise duration.
Purpose
In order to investigate the effect of the training duration we compared and analysed acute vs chronic exercise by using in silico technique and we performed two different bioinformatics analysis: tissue-specific and cardiovascular process specific.
Materials
Bioinformatics analysis miRNA targets predictions, data filtering and visualization as interaction networks were performed. We used multiMiR 1.4 R package, hemopoiesis, angiogenesis, cardiac muscle functions, muscle hypertrophy process was performed a screening of the GO terms for the presence of the key words using the biomaRt package in R, Gene-gene interaction data were retrieved from String App, Cytoscape. Enrichment analysis of Reactome and KEGG pathways using String App. p<0.05.
Results
Enrichment analysis of Reactome and Kegg pathways revealed strong regulation of senescence-related pathways, RUNX1 expression and activity, Ca2+ signaling involving AGO genes. For the first time our in silico analysis showed that AGO, HMGA2 genes may be associated with adaptive changes in response to exercise. Importantly, we found, that PI3K/AKT signalling (pathway incusing cell survival, growth, and proliferation) was present only in acute but not in chronic exercise.
Conclusions
In our analysis long-term training miRNA-gene target interaction was different than the short-term training. As PI3K/AKT signaling was present only in acute exercise, we suggest that not long-term but short-term training can be related with increased cell survival, enhanced cell proliferation, and decreased cell apoptosis.
Genes associated cardiac muscle function
Funding Acknowledgement
Type of funding source: Public grant(s) – National budget only. Main funding source(s): “Preludium” from the National Science Center, Poland
Collapse
Affiliation(s)
- M Postula
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - Z Wicik
- Sao Paulo University Medical School, Rheumatology Division, Sao Paulo, Brazil
| | - C Eyileten
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - A Soplinska
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - P Czajka
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - A Nowak
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - J Jarosz-Popek
- Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharma, Warsaw, Poland
| | - L Malek
- National Institute of Cardiology, Department of Epidemiology, Cardiovascular Disease Prevention and Health Promotion, Warsaw, Poland
| |
Collapse
|
40
|
Belkin M, Wussler D, Strebel I, Michou E, Kozhuharov N, Sabti Z, Nowak A, Flores D, Nestelberger T, Walter J, Boeddinghaus J, Zimmermann T, Koechlin L, Breidthardt T, Mueller C. Prognostic value of health-related quality of life in patients with acute dyspnea. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Previous studies have shown the prognostic value of health-related quality of life (HRQL) in stable and ambulatory chronic heart failure patients. However, it is unknown whether HRQL can predict all-cause mortality in patients presenting to the emergency department (ED) after acute onset of symptoms. In order to address this unmet need, the aim of this study was to assess the prognostic value of HRQL in patients with acute dyspnea caused by acute heart failure (AHF) and other dyspnea aetiologies for 360-day mortality.
Purpose
To assess prognostic value of HRQL using the generic EQ-5D and visual analogue scale (EQ VAS) in patients with acute dyspnea.
Methods
Basics in Acute Shortness of Breath EvaLuation (BASEL V) is a prospective, multicenter, diagnostic study enrolling adult patients presenting with acute dyspnea to the ED. For this analysis, only patients with a complete set of variables necessary for calculation of EQ-5D (range 0–10; with higher score indicating worse HRQL) and EQ VAS (range 0–100; with 100 being the best imaginable health state) at baseline were included. The endpoint was the prognostic value of EQ-5D and EQ VAS at 360 days of follow-up regarding all-cause death. Prognostic accuracy was calculated using c-statistics. In a cox regression analysis EQ-5D was treated as both, a continuous and categorical variable. Adjustments were made for clinically relevant covariates (age, sex, orthopnoea, edema, level of N-terminal pro-B-type natriuretic peptide (NT-proBNP) at presentation, history of coronary artery disease and chronic obstructive pulmonary disease, diuretics, β-blockers and ACE-inhibitors at discharge).
Results
Among 2605 patients enrolled, 1141 (43,8%) had a complete set of variables allowing the calculation of EQ-5D and EQ VAS. Of these patients 594 (52.1%) had an adjudicated final diagnosis of AHF. 211 (18.5%) patients died within 360 days of follow-up. Median EQ-5D was 3 (interquartile range (IQR) 1.5–5) and median EQ VAS was 50 (IQR 40–70). The prognostic accuracy for 360-day mortality was 0.65 (95% confidence interval ((CI) 0.61–0.69) and 0.58 (95% CI 0.54–0.62) for EQ-5D and EQ VAS, respectively (p=0.002). After combining EQ-5D and EQ VAS in a logistic regression model c-statistics regarding all-cause mortality within 360 days did not improve. The prognostic accuracy of EQ-5D was comparable to that of NT-proBNP (c-statistics 0.69, p=0.385). In an adjusted cox regression analysis the hazard ratio for patients with EQ-5D >4 was 2.2 (95% CI 1.7–2.9; p<0.001).
Conclusions
In patients presenting with acute dyspnea HRQL is a strong prognostic instrument. Independently of the aetiology of the dyspnea the prognostic value of the generic EQ-5D for 360-day mortality is comparable to NT-proBNP. Patients with an EQ-5D >4 are at significantly higher risk for mortality within 360 days.
Figure 1. Prognostic value of HRQL
Funding Acknowledgement
Type of funding source: Public grant(s) – National budget only. Main funding source(s): Swiss National Science Foundation, Swiss Heart Foundation
Collapse
Affiliation(s)
- M Belkin
- University Hospital Basel, Basel, Switzerland
| | - D Wussler
- University Hospital Basel, Basel, Switzerland
| | - I Strebel
- University Hospital Basel, Basel, Switzerland
| | - E Michou
- University Hospital Basel, Basel, Switzerland
| | | | - Z Sabti
- University Hospital Basel, Basel, Switzerland
| | - A Nowak
- University Hospital Basel, Basel, Switzerland
| | - D Flores
- University Hospital Basel, Basel, Switzerland
| | | | - J Walter
- University Hospital Basel, Basel, Switzerland
| | | | | | - L Koechlin
- University Hospital Basel, Basel, Switzerland
| | | | - C Mueller
- University Hospital Basel, Basel, Switzerland
| |
Collapse
|
41
|
Nowak A, Bartczak-Rutkowska A, Litwiniuk M, Kufel-Grabowska J, Marszalek S, Gorecki M, Malinowska M, Suchorska W, Dos J, Nowaczyk P, Dudek M, Marszalek A, Lesiak M, Straburzynska-Migaj E. The impact of chemotheraphy and supervised high-intensity interval physical activity on left ventricle strain and myocardial work parameters – SPORT NATHY TRIAL pilot study results. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Cardiotoxic effect of chemotheraphy represents known and challenging problem, thus search for potentially cardioprotective factors plays a key role in the contemporary cardio-oncology. Physical activity may allievate side effects of chemotheraphy and improve quality of live. Myocardial Work is a novel echocardiographic technique and promising tool for cancer patients assesement.
Purpose
The aim of this randomised pilot study was to assess left ventricle function using speckle tracking myocardial strain (2D STE) with Myocardial Work (MW) module in young women undergoing neoadjuvant chemotheraphy due to breast cancer and the impact of supervised high-intensity interval physical activity on these echocardiographic parameters.
Material and methods
We evaluated 24 women aged 27–41 (mean 34±4 yrs) with invasive breast cancer undergoing standard neoadjuvant chemotheraphy and randomized them into two groups: control - (CG, 15 pts) and experimental - with 6 months of supervised high-intensity interval exercise (SHIIEG, 9 pts). Every patient underwent echocardiographic examination 2D STE and MW before chemotheraphy and at 6 months follow-up. The following parameters were evaluated: Global Longitudinal Strain (GLS), Global Work Index (GWI), Global Constructive Work (GCW), Global Work Efficiency (GWE), Global Waste Work (GWW).
Results
Following parameters significantly decreased after chemotherapy: EF (65.4±5.7 vs 60.5±7.0%; p=0.003), GLS (20.4±2.5 vs 18.4±2.0%; p=0.001), GWI (1835.4±206.9 vs 1594.1±228.3 mmHg%; p=0.0004), GCW (2240.5±270.8 vs 1884.9±241.3 mmHg%; p=0.0001), GWE (95.9±1.5 vs 94.9±1.7%; p=0.02). No signifficant changes in GWW (78.6±36.4 vs 80.5±32.2 mmHg%; p=0.7) were found.
The comparison of control (CG) and experimental group (SHIIEG) at 6 months follow-up revealed no signifficant differences in the following parameters: GLS (p=0.9), GWI (p=0.3), GCW (p=0.2), GWE (p=0.3) and GWW (p=0.5). However analysis of relative percentage change from baseline in GLS and GWW (Δ%GLS, Δ%GWW) almost reached statistical significance [for CG and SHIIEG respectively: Δ%GLS (−15.6 vs −4.4; p=0.07), Δ%GWW (+39.4 vs −7.3; p=0.06)].
Conclusions
Neoadjuvant chemotherapy administered in young women with invasive breast cancer impaires the function of left ventricle after 6 month of theraphy, resulting in decrease of GLS, GWI, GCW and GWE. The supervised high-intensity interval physical activity impacts the relative change of GLS (Δ%GLS) and GWW (Δ%GWW), therefore may have cardioprotective effect on left ventricle function.
Funding Acknowledgement
Type of funding source: Public hospital(s). Main funding source(s): Greater Poland Cancer Centre, Poznan, Poland
Collapse
Affiliation(s)
- A Nowak
- Poznan University of Medical Sciences, University Hospital of Lord's Transfiguration, 1st Department of Cardiology, Poznan, Poland
| | - A Bartczak-Rutkowska
- Poznan University of Medical Sciences, University Hospital of Lord's Transfiguration, 1st Department of Cardiology, Poznan, Poland
| | - M Litwiniuk
- Poznan University of Medical Sciences, Greater Poland Cancer Centre, Department of Oncologic Pathology and Prophylaxis, Poznan, Poland
| | - J Kufel-Grabowska
- Poznan University of Medical Sciences, Greater Poland Cancer Centre, Department of Electroradiology, Poznan, Poland
| | - S Marszalek
- Poznan University of Medical Sciences, Greater Poland Cancer Centre, Department of Physiotherapy, Poznan, Poland
| | - M Gorecki
- Poznan University School of Physical Education, Greater Poland Cancer Centre, Department of Physiotherapy, Faculty of Physical Education in Gorzow Wielkopolski, Poznan, Poland
| | - M Malinowska
- Greater Poland Cancer Centre, Department of Rehabilitation, Poznan, Poland
| | - W Suchorska
- Poznan University of Medical Sciences, Greater Poland Cancer Centre, Department of Electroradiology, Poznan, Poland
| | - J Dos
- Poznan University School of Physical Education, Greater Poland Cancer Centre, Department of Physiotherapy, Faculty of Physical Education in Gorzow Wielkopolski, Poznan, Poland
| | - P Nowaczyk
- Greater Poland Cancer Centre, Brest Surgical Oncology Department, Poznan, Poland
| | - M Dudek
- Poznan University of Medical Sciences, University Hospital of Lord's Transfiguration, 1st Department of Cardiology, Poznan, Poland
| | - A Marszalek
- Poznan University of Medical Sciences, Greater Poland Cancer Centre, Department of Oncologic Pathology and Prophylaxis, Poznan, Poland
| | - M Lesiak
- Poznan University of Medical Sciences, University Hospital of Lord's Transfiguration, 1st Department of Cardiology, Poznan, Poland
| | - E Straburzynska-Migaj
- Poznan University of Medical Sciences, University Hospital of Lord's Transfiguration, 1st Department of Cardiology, Poznan, Poland
| |
Collapse
|
42
|
Wussler D, Belkin M, Strebel I, Kozhuharov N, Sabti N, Nowak A, Michou E, Flores D, Gualandro D, Breidthardt T, Mueller C. Direct comparison of BNP and NT-proBNP for mortality prediction in patients with acute dyspnea. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
It is unclear whether BNP or NT-proBNP, their admission or discharge measurement or percentage change during hospitalization are preferable for mortality prediction in patients with acute dyspnea.
Purpose
To directly compare BNP and NT-proBNP regarding their potential in mortality prediction in patients with acute dyspnea and in patients with dyspnea due to AHF.
Methods
In a prospective multicenter diagnostic study the presence of AHF was centrally adjudicated by two independent cardiologists among patients presenting with acute dyspnea. The levels of BNP and NT-proBNP were measured at presentation and discharge. Patients were stratified according to their natriuretic peptide response (responders vs. non-responders: natriuretic peptide decrease ≥25% vs. <25% before discharge). Prognostic accuracy for 720-day mortality was quantified using the area under the receiver-operating-characteristic curve (AUC). Cox proportional hazard models were constructed to identify significant predictors for 720-day mortality.
Results
Among 1156 patients presenting with acute dyspnea, 353 (30.5%) died within 720 days of follow-up. Prognostic accuracy for death at 720 days was significantly higher for discharge compared to admission measurements for BNP (AUC 0.750 vs. 0.711, p<0.001) and NT-proBNP (AUC 0.769 vs. 0.720, p<0.001). When directly comparing discharge measurements, NT-proBNP levels exhibited a significantly higher accuracy (p=0.013). 632 (54.6%) and 600 (51.9%) patients were BNP and NT-proBNP non-responders, respectively. Among BNP and NT-proBNP non-responders 202 (32%) and 207 (34.5%) patients died within 720 days of follow-up. After adjusting for common covariates NTproBNP response was the strongest predictor for 720-day mortality in a Cox regression model (Hazard ratio for NT-proBNP non-responders: 2.096 (95% CI 1.550–2.835), p<0.001). Results were confirmed in a sensitivity analysis of 687 (59.4%) patients with adjudicated AHF.
Conclusion
Percentage change of NT-proBNP during hospitalization seems to be the strongest predictor for long-term mortality in patients with acute dyspnea in general and in those with dyspnea due to AHF in particular.
ROC curve for direct comparison
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- D Wussler
- University Hospital Basel, Department of Cardiology, Basel, Switzerland
| | - M Belkin
- University Hospital Basel, Department of Cardiology, Basel, Switzerland
| | - I Strebel
- University Hospital Basel, Department of Cardiology, Basel, Switzerland
| | - N Kozhuharov
- University Hospital Basel, Department of Cardiology, Basel, Switzerland
| | - N Sabti
- University Hospital Basel, Department of Cardiology, Basel, Switzerland
| | - A Nowak
- University Hospital Zurich, Zurich, Switzerland
| | - E Michou
- University Hospital Basel, Department of Cardiology, Basel, Switzerland
| | - D Flores
- University Hospital Basel, Department of Cardiology, Basel, Switzerland
| | - D Gualandro
- University Hospital Basel, Department of Cardiology, Basel, Switzerland
| | - T Breidthardt
- University Hospital Basel, Department for Internal Medicine, Basel, Switzerland
| | - C Mueller
- University Hospital Basel, Department of Cardiology, Basel, Switzerland
| |
Collapse
|
43
|
Patil S, Linge A, Tawk B, Gurtner K, Großer M, Lohaus F, Gudziol V, Nowak A, Tinhofer I, Budach V, Stuschke M, Balermpas P, Rödel C, Schäfer H, Grosu A, Abdollahi A, Debus J, Belka C, Combs S, Mönnich D, Zips D, Baretton G, Krause M, Baumann M, Löck S. OC-0570: Validating gene signatures in locally advanced HNSCC patients treated by PORT-C and in xenografts. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00592-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
44
|
Michou E, Wussler D, Belkin M, Strebel I, Kozhuharov N, Sabti Z, Nowak A, Lopez Ayala P, Flores D, Gualandro D, Breidthardt T, Mueller C. Quantifying inflammation using interleukin-6 for improved phenotyping and risk stratification in acute heart failure. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Acute heart failure (AHF) is the most common cause of hospital admission and continues to have unacceptable high rates of mortality and morbidity. In contrast to acute myocardial infarction, the pathophysiology of AHF is incompletely understood and risk-prediction is poorly defined.
Aim
We aimed to quantify systemic inflammation to assess its possible role in the pathophysiology and risk stratification of patients with AHF.
Methods
Using a novel Interleukin-6 immunoassay with unprecedented sensitivity (limit of detection 0.01ng/l) we quantified systemic inflammation in unselected patients presenting with acute dyspnea to the emergency department in a multicenter study. Plasma concentrations of NT-proBNP (open label) and Interleukin-6 (blinded) were measured at presentation and at discharge. The final diagnosis of AHF and the AHF phenotype were adjudicated by two independent cardiologists. 1-year mortality was the prognostic endpoint.
Results
Among 2042 patients, 1026 (50.2%) had an adjudicated diagnosis of AHF. Interleukin-6 concentrations were significantly higher in AHF patients compared to patients with other causes of dyspnoea (11.2 [6.1–26.5] ng/l vs 9.0 [3.2–32.3] ng/l, p<0.0005). Among patients with AHF Interleukin-6 concentrations were elevated (>4.45ng/l) in 83.7% of them. Among the different AHF phenotypes, Interleukin-6 concentrations were highest in patients with cardiogenic shock (25.7 [14.0–164.2] ng/l) and lowest in patients with hypertensive HF (9.3 [4.8–21.6] ng/l, p=0.001). Inflammation as quantified by Interleukin-6 was a strong predictor of 1-year mortality both in AHF as well as in other causes of acute dyspnea (Figure). During in-hospital treatment Interleukin-6 concentrations significantly decreased in AHF patients. However, changes in the extend of systemic inflammation (delta Interleukin-6) were poorly correlated with changes in hemodynamic stress as quantified by NT-proBNP (delta NT-proBNP, Φc=0.11, p=0.004).
Conclusions
An unexpectedly high percentage of patients with AHF have subclinical systemic inflammation that can be quantified by Interleukin-6, which seems to contribute to the AHF phenotype and to the risk of death.
Kaplan Meier curves for mortality
Funding Acknowledgement
Type of funding source: Foundation. Main funding source(s): Swiss National Science Foundation, Swiss Heart Foundation, European Union, Stiftung für kardiovaskuläre Forschung Basel, University of Basel, University Hospital Basel
Collapse
Affiliation(s)
- E Michou
- University Hospital Basel, Basel, Switzerland
| | - D Wussler
- University Hospital Basel, Basel, Switzerland
| | - M Belkin
- University Hospital Basel, Basel, Switzerland
| | - I Strebel
- University Hospital Basel, Basel, Switzerland
| | | | - Z Sabti
- University Hospital Basel, Basel, Switzerland
| | - A Nowak
- University Hospital Basel, Basel, Switzerland
| | | | - D Flores
- University Hospital Basel, Basel, Switzerland
| | - D Gualandro
- University Hospital Basel, Basel, Switzerland
| | | | - C Mueller
- University Hospital Basel, Basel, Switzerland
| |
Collapse
|
45
|
Piggott T, Brozek J, Nowak A, Dietl H, Dietl B, Saz-Parkinson Z, Mirzayev F, González-Angulo L, Yepes-Nuñez JJ, Mustafa RA, Leontiadis GI, Brignardello-Petersen R, Alonso-Coello P, Schünemann HJ. Using GRADE evidence to decision frameworks to choose from multiple interventions. J Clin Epidemiol 2020; 130:117-124. [PMID: 33127374 DOI: 10.1016/j.jclinepi.2020.10.016] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2020] [Revised: 09/29/2020] [Accepted: 10/22/2020] [Indexed: 12/18/2022]
Abstract
BACKGROUND AND OBJECTIVE Guideline development groups or other health care decision makers frequently encounter situations that require a simultaneous comparison of multiple interventions. This sometimes becomes apparent either when they identify questions of interest, before they formulate recommendations, or it may surface only when recommendations have already been formulated based on pairwise comparisons. METHODS Using examples from the World Health Organization, the European Commission, and a professional society, we developed a flexible approach to developing recommendations when a multiple-intervention comparison (MC) is needed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) evidence to decision (EtD) frameworks. We iteratively refined this approach through user testing and then included a module in GRADE's official software GRADEpro to test the approach in two real and one theoretical guideline recommendations. RESULTS We found the approach feasible and that all EtD criteria should be considered in an MC approach. We judged that guideline development groups and other decision makers will benefit from the availability of a network meta-analyses (NMA) of intervention effects to support decisions; however, NMA supports only one of many criteria, that is, the balance of health benefits and harms, and is therefore helpful, but not essential to the approach we propose. When similar but not identical comparators are used to address MC, challenges may arise with intransitivity and the relative rankings of interventions. CONCLUSION We successfully applied the MC approach and software module in generating recommendations across different scenarios and identified challenges. The MC approach allows guideline groups and other decision makers to transparently and critically assess multiple options for a given health question. Application of the approach by others may lead to refinement and allow for better understanding of its impact in developing recommendations and making choices.
Collapse
Affiliation(s)
- Thomas Piggott
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada
| | - Jan Brozek
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada
| | - Artur Nowak
- Evidence Prime, Hamilton, Canada and Krakow, Poland
| | - Helena Dietl
- Evidence Prime, Hamilton, Canada and Krakow, Poland
| | - Bart Dietl
- Evidence Prime, Hamilton, Canada and Krakow, Poland
| | | | - Fuad Mirzayev
- Global TB Program, World Health Organization, Geneva, Switzerland
| | | | - Juan José Yepes-Nuñez
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada; School of Medicine, Universidad de Los Andes, Bogotá, Colombia
| | - Reem A Mustafa
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada; Department of Medicine, University of Kansas Health System, Kansas City, USA
| | | | | | - Pablo Alonso-Coello
- Iberoamerican Cochrane Center-Servicio de Epidemiología Clínica y Salud Pública, Biomedical Research Institute (IIB-Sant Pau), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP), Barcelona, Spain
| | - Holger J Schünemann
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada; Department of Medicine, McMaster University, Hamilton, Canada; Institut für Evidence in Medicine, Medical Center & Faculty of Medicine, University of Freiburg, Freiburg, Germany.
| |
Collapse
|
46
|
Baas P, Scherpereel A, Nowak A, Fujimoto N, Peters S, Tsao A, Mansfield A, Popat S, Jahan T, Antonia S, Oulkhouir Y, Bautista Y, Cornelissen R, Greillier L, Grossi F, Kowalski D, Rodriguez-Cid J, Aanur P, Baudelet C, Zalcman G. ID:2908 First-Line Nivolumab + Ipilimumab vs Chemotherapy in Unresectable Malignant Pleural Mesothelioma: CheckMate 743. J Thorac Oncol 2020. [DOI: 10.1016/j.jtho.2020.08.004] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
47
|
Kufel-Grabowska J, Litwiniuk M, Marszałek S, Górecki M, Malinowska M, Doś J, Marszalek A, Suchorska W, Lesiak M, Straburzynska-Migaj E, Nowak A, Bartczak-Rutkowska A, Dudek M, Nowaczyk P, Jedrzejczak P. 192P Strategies and results of oncofertility counselling in young breast cancer patients. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.03.130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
48
|
Jaroszuk-Ściseł J, Nowak A, Komaniecka I, Choma A, Jarosz-Wilkołazka A, Osińska-Jaroszuk M, Tyśkiewicz R, Wiater A, Rogalski J. Differences in Production, Composition, and Antioxidant Activities of Exopolymeric Substances (EPS) Obtained from Cultures of Endophytic Fusarium culmorum Strains with Different Effects on Cereals. Molecules 2020; 25:E616. [PMID: 32019268 PMCID: PMC7037457 DOI: 10.3390/molecules25030616] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2019] [Revised: 01/24/2020] [Accepted: 01/28/2020] [Indexed: 11/16/2022] Open
Abstract
Exopolymeric substances (EPS) can determine plant-microorganism interactions and have great potential as bioactive compounds. The different amounts of EPS obtained from cultures of three endophytic Fusarium culmorum strains with different aggressiveness-growth promoting (PGPF), deleterious (DRMO), and pathogenic towards cereal plants-depended on growth conditions. The EPS concentrations (under optimized culture conditions) were the lowest (0.2 g/L) in the PGPF, about three times higher in the DRMO, and five times higher in the pathogen culture. The EPS of these strains differed in the content of proteins, phenolic components, total sugars, glycosidic linkages, and sugar composition (glucose, mannose, galactose, and smaller quantities of arabinose, galactosamine, and glucosamine). The pathogen EPS exhibited the highest total sugar and mannose concentration. FTIR analysis confirmed the β configuration of the sugars. The EPS differed in the number and weight of polysaccharidic subfractions. The EPS of PGPF and DRMO had two subfractions and the pathogen EPS exhibited a subfraction with the lowest weight (5 kDa). The three EPS preparations (ethanol-precipitated EP, crude C, and proteolysed P) had antioxidant activity (particularly high for the EP-EPS soluble in high concentrations). The EP-EPS of the PGPF strain had the highest antioxidant activity, most likely associated with the highest content of phenolic compounds in this EPS.
Collapse
Affiliation(s)
- Jolanta Jaroszuk-Ściseł
- Department of Industrial and Environmental Microbiology, Maria Curie-Sklodowska University, Akademicka St. 19, 20-033 Lublin, Poland; (R.T.); (A.W.)
| | - Artur Nowak
- Department of Industrial and Environmental Microbiology, Maria Curie-Sklodowska University, Akademicka St. 19, 20-033 Lublin, Poland; (R.T.); (A.W.)
| | - Iwona Komaniecka
- Department of Genetic and Microbiology, Maria Curie-Sklodowska University, Akademicka St. 19, 20-033 Lublin, Poland; (I.K.); (A.C.)
| | - Adam Choma
- Department of Genetic and Microbiology, Maria Curie-Sklodowska University, Akademicka St. 19, 20-033 Lublin, Poland; (I.K.); (A.C.)
| | - Anna Jarosz-Wilkołazka
- Department of Biochemistry and Biotechnology, Maria Curie-Sklodowska University, Akademicka St. 19, 20-033 Lublin, Poland; (A.J.-W.); (M.O.-J.); (J.R.)
| | - Monika Osińska-Jaroszuk
- Department of Biochemistry and Biotechnology, Maria Curie-Sklodowska University, Akademicka St. 19, 20-033 Lublin, Poland; (A.J.-W.); (M.O.-J.); (J.R.)
| | - Renata Tyśkiewicz
- Department of Industrial and Environmental Microbiology, Maria Curie-Sklodowska University, Akademicka St. 19, 20-033 Lublin, Poland; (R.T.); (A.W.)
- Military Institute of Hygiene and Epidemiology, Lubelska St. 2, 24-100 Puławy, Poland
| | - Adrian Wiater
- Department of Industrial and Environmental Microbiology, Maria Curie-Sklodowska University, Akademicka St. 19, 20-033 Lublin, Poland; (R.T.); (A.W.)
| | - Jerzy Rogalski
- Department of Biochemistry and Biotechnology, Maria Curie-Sklodowska University, Akademicka St. 19, 20-033 Lublin, Poland; (A.J.-W.); (M.O.-J.); (J.R.)
| |
Collapse
|
49
|
Dulski M, Dudek K, Podwórny J, Sułowicz S, Piotrowska-Seget Z, Malarz K, Mrozek-Wilczkiewicz A, Wolnica K, Matus K, Peszke J, Nowak A. Impact of temperature on the physicochemical, structural and biological features of copper-silica nanocomposites. Mater Sci Eng C Mater Biol Appl 2019; 107:110274. [PMID: 31761190 DOI: 10.1016/j.msec.2019.110274] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/21/2019] [Revised: 09/09/2019] [Accepted: 10/02/2019] [Indexed: 01/07/2023]
Abstract
Classical wet chemical synthesis was used to fabricate a hybrid composite that contained copper nanoparticles (average size ∼1 nm), which were embedded into a silicon oxide carrier. The structural and chemical alternations in the copper-functionalized silica were investigated in systems that were sintered at 573 K, 873 K, 1173 K, and 1473 K. A general trend, which was associated with the transformation of metallic copper with a cubic structure into copper(II) oxide with a monoclinic structure in the heat-treated systems, was found. XPS and FTIR spectroscopies also revealed the presence of copper(I) oxide, which formed a shell around the CuO. SEM and TEM showed gradual densification of the hybrid system at ever higher sintering temperatures, which corresponded with the gradual copper agglomeration. A temperature of 873 K was determined to be the temperature at which amorphous silica was transformed into cristoballite and tridymite, as well as the formation of a bulk-like copper structure. In relation to the physicochemical and structural data, high antimicrobial features that had a relatively low toxicity effect on the normal human fibroblasts (NHDF) below 250 mg/L was found for the initial copper-silica composite and the samples that were sintered at 573 K. In turn, a significant decrease in the biological impact was observed in the samples that were sintered at temperatures above 573 K. As a result, the paper discusses the model of structural modifications in copper-silica nanocomposite concerning their biological impact that was developed.
Collapse
Affiliation(s)
- M Dulski
- Institute of Materials Science, University of Silesia, 75 Pułku Piechoty 1a, 41-500, Chorzów, Poland; Silesian Center for Education and Interdisciplinary Research, 75 Pułku Piechoty 1A, 41-500, Chorzów, Poland.
| | - K Dudek
- Łukasiewicz Research Network - Institute of Ceramics and Building Materials, Refractory Materials Division in Gliwice, Toszecka 99, 44-100, Gliwice, Poland
| | - J Podwórny
- Łukasiewicz Research Network - Institute of Ceramics and Building Materials, Refractory Materials Division in Gliwice, Toszecka 99, 44-100, Gliwice, Poland
| | - S Sułowicz
- Department of Microbiology, University of Silesia, Jagiellońska 28, 40-032, Katowice, Poland
| | - Z Piotrowska-Seget
- Department of Microbiology, University of Silesia, Jagiellońska 28, 40-032, Katowice, Poland
| | - K Malarz
- Silesian Center for Education and Interdisciplinary Research, 75 Pułku Piechoty 1A, 41-500, Chorzów, Poland; A. Chełkowski Institute of Physics, University of Silesia, 75 Pułku Piechoty 1, 41-500, Chorzów, Poland
| | - A Mrozek-Wilczkiewicz
- Silesian Center for Education and Interdisciplinary Research, 75 Pułku Piechoty 1A, 41-500, Chorzów, Poland; A. Chełkowski Institute of Physics, University of Silesia, 75 Pułku Piechoty 1, 41-500, Chorzów, Poland
| | - K Wolnica
- Silesian Center for Education and Interdisciplinary Research, 75 Pułku Piechoty 1A, 41-500, Chorzów, Poland; A. Chełkowski Institute of Physics, University of Silesia, 75 Pułku Piechoty 1, 41-500, Chorzów, Poland
| | - K Matus
- Department of Engineering Materials and Biomaterials, Silesian University of Technology, Konarskiego 18A, 44-100, Gliwice, Poland
| | - J Peszke
- Silesian Center for Education and Interdisciplinary Research, 75 Pułku Piechoty 1A, 41-500, Chorzów, Poland; A. Chełkowski Institute of Physics, University of Silesia, 75 Pułku Piechoty 1, 41-500, Chorzów, Poland
| | - A Nowak
- Silesian Center for Education and Interdisciplinary Research, 75 Pułku Piechoty 1A, 41-500, Chorzów, Poland; A. Chełkowski Institute of Physics, University of Silesia, 75 Pułku Piechoty 1, 41-500, Chorzów, Poland
| |
Collapse
|
50
|
Leonhardt H, Franke A, Nowak A, McLeod N, Lauer G. Clinical experience and results with a Rhombic Plate for transoral endoscopically-assisted osteosynthesis of fractures of the condylar neck. Br J Oral Maxillofac Surg 2019; 57:1063-1067. [PMID: 31594713 DOI: 10.1016/j.bjoms.2019.09.016] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2019] [Accepted: 09/18/2019] [Indexed: 10/25/2022]
Abstract
The intraoral approach is favoured by many patients and surgeons for the treatment of fractures of the condylar neck, but the limited space offered by this approach can make positioning and fixation of the osteosynthesis plate difficult. A rhombic-shaped plate was designed specifically for use with the intraoral approach, and introduced into our clinical practice in 2012. We present the clinical and functional results in 81 patients with 98 fractures of the condylar neck who we have treated with this technique. Of these six required surgical revision, and ultimately all but two had satisfactory occlusion and mandibular function. Our complication rate of 6/81 (7.4%) compares favourably with those reported elsewhere, and confirms that open reduction and internal fixation of condylar fractures using the Rhombic plate through an intra-oral approach provides good outcomes.
Collapse
Affiliation(s)
- H Leonhardt
- University Hospital Carl Gustav Carus at Technical University Dresden, Clinic of Maxillofacial Surgery, Fetscherstr. 74, 01309 Dresden, Germany.
| | - A Franke
- University Hospital Carl Gustav Carus at Technical University Dresden, Clinic of Maxillofacial Surgery, Fetscherstr. 74, 01309 Dresden, Germany
| | - A Nowak
- University Hospital Carl Gustav Carus at Technical University Dresden, Clinic of Maxillofacial Surgery, Fetscherstr. 74, 01309 Dresden, Germany
| | - Nmh McLeod
- Barts Health NHS Trust, The Royal London Dental Hospital, Turner Street, Whitechapel, London, E1 1BB, United Kingdom
| | - G Lauer
- University Hospital Carl Gustav Carus at Technical University Dresden, Clinic of Maxillofacial Surgery, Fetscherstr. 74, 01309 Dresden, Germany
| |
Collapse
|